Lung Cancer News

Lung Cancer News Feed
Lung Cancer News

Follow Us on Facebook

Shop for Us

Call to Action

Every 2 minutes someone is diagnosed with lung cancer. Help us change that statistic.

Bookmark and Share
Lung Cancer in the News: 2008 PDF Print E-mail

January | February | March | April | May | June | July
| August | September | October | November | December


Week Ending 12/28/08

Curing Cancer Takes Heart - or Heart Hormones, Maybe
"The world of medical research is taking growing notice of Vesely's discoveries, made in a maze of small, crowded labs at the James A. Haley VA Medical Center. The widowed father of five, whose wife died of breast cancer in 2002, has big, seemingly impossible hopes that four hormones manufactured by the heart may one day save millions of lives."

Cancer Deaths Cost U.S. Billions
"No matter how it's measured, the economic cost of cancer deaths in the U.S. runs in the billions, according to two new studies."

Common Food Additive Found to Increase Risk and Speed Spread of Lung Cancer
"New research in an animal model suggests that a diet high in inorganic phosphates, which are found in a variety of processed foods including meats, cheeses, beverages, and bakery products, might speed growth of lung cancer tumors and may even contribute to the development of those tumors in individuals predisposed to the disease."

Experts Identify Gene Variants Linked to Lung Cancer
"Researchers in China and the United States have identified mutations of two genes which appear to make ethnic Chinese more susceptible to lung cancer, they wrote in the journal Cancer."

Vitamin Supplements Don't Fight Cancer, Studies Show
"A series of trials also shows that taking vitamins and minerals has no effect on preventing strokes, heart disease or other ailments."

Senators Want Probe of Merced Case
"Both California's U.S. senators have called for a full review of allegations by residents in a Merced neighborhood who claim that a nearby manufacturing plant contaminated their drinking water with a cancer-causing chemical."

Week Ending 12/14/08

Inuits Top Lung Cancer Rates: Study
MONTREAL (AFP) — “Inuits have the highest lung cancer rates in the world, largely attributed to widespread smoking among the population, researchers said Friday.”

Are Diesel Truckers at 'Increased Lung Cancer Risk' ?
“Trucking company workers are at an increased risk of developing lung cancer due to regular exposure to diesel exhaust, say researchers.”

Cancer Expected to Become Leading Cause of Death Worldwide
( - News 12/12/2008) “According to information from the World Health Organization’s (WHO) International Agency for Research on Cancer (IARC), cancer will become the leading cause of death worldwide in the year 2010.”

Killer cancers: Pancreatic and lung cancers difficult to detect early
“Art Coltrin had no inkling that anything was wrong until his face and eyes turned yellow, the classic symptoms of jaundice. Dr. Yang Chen of Denver, the director of endoscopy at the University of Colorado Hospital, had a cough for about two months that he attributed to allergies and a backache that he thought was caused by strain on his back at work.”

Ron Carey, Who Led Teamsters Reforms, Dies at 72
“Ron Carey, a parcel truck driver from Queens who became president of the Teamsters union and led a successful strike by 185,000 workers against United Parcel Service, but was then ousted in a campaign finance scandal, died on Thursday in Queens. He was 72.”

Lauderhill Woman Gives New Look to Cancer Fighters
“A cancer survivor's organization aims to help others with the disease by offering plenty of emotional support and free wigs to those going through chemotherapy.”

Local Cancer Victims Continue Their Fight
INDIANA - “Post-Tribune staff writer Piet Levy revisits four people profiled in September as they confronted lung cancer, part of a package of stories reflecting the high incidence of the disease in Indiana.“

Week Ending December 7, 2008

ERBITUX(R) Supplemental Biologics License Application for Advanced Non-Small Cell Lung Cancer Submitted to U.S. Food and Drug Administration
“ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company today announced that they have submitted an application to the U.S. Food and Drug Administration (FDA) to broaden the use of ERBITUX(R) (cetuximab) to include first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) in combination with platinum-based chemotherapy (cisplatin/vinorelbine).”

Stanford Researchers Develop Blood Scanner That Can Detect Cancer
“A new blood scanner developed by Stanford researchers may allow doctors to identify cancer in patients sooner, and treat the disease faster, say researchers. It can search for cancer-associated proteins in a blood sample and returns results in less than an hour.”

Cancer Hits Poor Hard
“Being poor in Colorado continues to be a big risk factor in contracting cancer and dying from it. A new groundbreaking study, "Cancer & Poverty: Colorado: 1995-2006," found this to be true across all types of cancers and points to a multitude of causes.”

Stressing Cancer Cells to Improve Cancer Therapy
“South Dakota State University scientists are investigating whether “stressing” cancer cells can make cancer radiation treatment and chemotherapy more effective.”

Educating on Lung cancer
Mom's goal is to stop students' tobacco use

“The year is nearly over, and for nearly 162,000 Americans, it is the year that lung cancer claimed their lives. No other cancer claimed as many lives.”

Thousands gather to honor the life of Sgt. Terry Polston
“Thousands gathered to remember the life of a beloved DARE officer Sunday afternoon. Sgt. Terry Polston of Warsaw died earlier this week after a long battle with lung cancer.”


Week Ending November 30, 2008

New Cases of Cancer Decline in the U.S.
“The incidence of new cancer cases has been falling in recent years in the United States, the first time such an extended decline has been documented, researchers reported Tuesday.”

New Cancer Vaccine May Hold Promise For African-American Lung Patients
“Lung cancer continues to be a most deadly enemy for African-Americans and other minorities. Despite recent improvements in diagnosis and treatment, lung cancer remains the leading cause of cancer death among African-Americans.”

Emory Researchers Caution against Widespread CT Screening for Lung Cancer
“While CT-based screenings for cancers of the breast, colon and prostate have saved many lives, the complexity of lung cancer makes such screenings thus far unreliable and inconclusive in terms of reducing overall mortality, caution Emory University researchers.”

Maui Helps Pursue Cancer Cure
“Clinical trials offer cancer patients access to new investigational drugs and therapies, which may be effective against their particular type and extent of disease. Most of our participants are from Oahu, where the infrastructure exists for conducting the trials.”

FTC Rescinds Guidance for Cigarette Ads
“The Federal Trade Commission on Wednesday rescinded guidance it issued 42 years ago that has allowed tobacco companies to make claims about tar and nicotine levels based on testing by a machine.”

Norwalk Hospital is first to open international study of new lung cancer drug
“The Whittingham Cancer Center at Norwalk Hospital is pleased to usher in National Lung Cancer Month by being the first in the world to activate an important new study for patients affected by the disease.”

Free to Breathe 5K events Raise Funding and Awareness of Lung Cancer
Raleigh, NC—“Early morning rain showers did nothing to deter the more than 900 participants who walked and ran in the second annual Duke Cancer Center Raleigh Free to Breathe® 5K Run/Walk and Rally for lung cancer at North Carolina State Centennial Campus Saturday. The event, which was organized by the North Carolina Lung Cancer Partnership, was dedicated to raising funding and awareness of the number one cancer killer in this country.”

Week Ending November 23, 2008

Iressa Proves Just As Effective As Chemotherapy For Lung Cancer
ScienceDaily — “Gefitinib, also known as Iressa, the once-promising targeted therapy for the treatment of non-small cell lung cancer, has proven as effective as chemotherapy as a second-line therapy for the disease with far fewer side effects, according to an international Phase III clinical trial, led by researchers at The University of Texas M. D. Anderson Cancer Center.”

Lung Cancer May Be Growing Epidemic Among Women
Local Woman Battles Disease

“Which cancer kills more Americans than any other? The answer is lung cancer, and if you're surprised you're in good company. NewsCenter 5's Heather Unruh profiled a local woman in the hopes of shinning a light on the growing epidemic.”

Cancer Survival Rates Impact Type of Web Communities Used by Patients
“Online support communities for high survival rate cancers contain a greater amount of emotional support content than online support communities for cancers with low survival rates, according to a new study from the University of Michigan Health System and the VA Ann Arbor Healthcare System.”

Cancer Linked to Behavior in Elderly
(Ivanhoe Newswire) – “About 80 percent of cancer diagnoses occur in the elderly, but many of their risk factors for the disease are behavioral, a new study revealed. The Duke University study was done to estimate the impact measurable risk factors have on cancer in the elderly. It revealed more than 80 percent of known risk factors in individuals 65 years of age or older are potentially preventable.”

Most are Unaware that Lung Cancer, a Preventable Disease, is Also the Leading Cause of Cancer-Related Deaths in the U.S.
MARQUETTE – “Puffing on a cigarette might seem harmless now, but later could be deadly. Chronic smoking is the leading cause of lung cancer, a disease that less than ten percent survive five years after diagnosis.”

Gefitinib Superior to Chemotherapy Among Asians with Lung Cancer
“For carefully selected Asian patients with non-small-cell lung cancer, the tyrosine kinase inhibitor gefitinib (Iressa) significantly improved progression-free survival compared with the standard carboplatin (Paraplatin) and paclitaxel (Taxol), researchers reported here.”

New Factor Raised for Ex-Smokers' Lung Cancer RIsk
“Scientists believe they may have worked out why some former smokers succumb to lung cancer while others do not. Disrupted methylation, a vital process which regulates gene expression during normal development, could potentially be to blame for the distinction.”

Genetic Trait Could Predict Lung Cancer
(HealthDay News) – “Canadian scientists may have discovered a genetic trait that could provide an early indication of which former smokers will develop lung cancer. The research, reported Tuesday at the American Association for Cancer Research conference in Washington, D.C., is still in the preliminary stages.”

Week Ending November 16. 2008

Smoking Rate is Declining in U.S.
Nearly 1 in 5 Americans Smoke Cigarettes

“The percentage of Americans who smoke cigarettes has fallen below 20% for the first time since at least the mid-1960s, according to a new report. The CDC says in its Morbidity and Mortality Weekly Report that the prevalence of smoking fell in 2007 to 19.8%, nearly a full percentage point from 20.8% in 2006.”

Lung Cancer Genetics Different in Black Patients: Study
(HealthDay News) – “Non-small cell lung tumors tend to have a different genetic makeup in blacks than in whites, a finding that may explain why treatment and outcomes are different among races, a new study says.”

Lung Cancer Patients Get Blamed for Their Disease
Survey finds nearly two-thirds of Americans believe so, even though most victims don't smoke at diagnosis

(HealthDay News) – “A majority of Americans, including many health-care workers, believe that people who have lung cancer are at least partly to blame for their disease, a new survey finds.”

Emphasis on Facts, Personalized Medicine for Lung Cancer Awareness Month
“With more than 215,000 Americans estimated to be diagnosed with lung cancer in 2008, Moffitt Cancer Center is doing its part to fight this disease by launching an awareness and education initiative addressing the facts surrounding lung cancer and showcasing how personalized medicine treatment techniques are breaking new ground for those diagnosed.”

Gender Is Key Factor In Determining Overall Survival Of Lung Cancer Patients
(ScienceDaily)— “Even though some combinations of gender, race and/or marital status can factor into the overall survival of nonoperative non-small cell lung cancer patients, gender is the most significant factor impacting overall survival, according to a study presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the University of Chicago.”

Two Chromium Studies in City Differ on Lung Cancer Threat
NEW JERSEY – “A new state study has found a correlation between lung cancer rates and exposure to chromium in Jersey City over the past three decades, but another recent investigation found little exposure in residences over the past two years, according to summaries of the two studies.”

November is Lung Cancer Awareness Month
INDIANA – “Indiana joins other states in observing Lung Cancer Awareness Month, a national campaign to raise awareness and educate Americans about the causes and dangers of lung cancer, each November.”

November is Lung Cancer Awareness Month
Join us November 23rd as Brittany's Battle, Inc. hosts Brittany's Annual Angel Gala - a Fundraiser for UNC Lineberger Cancer Center.“Brittany Coppedge was only 19 years old when she was diagnosed with stage 4 lung cancer. She was immediately admitted to UNC where she waged a courageous and graceful battle against the disease.“

Support Group Offering Information on Diagnosis, Treatment of Lung Cancer
“Lung cancer remains the leading cancer killer in America, according to the American Lung Association. Central Christian Cancer Support Group is offering the latest information on diagnosing and treating lung cancer at its upcoming monthly meeting, slated for 4 p.m. Nov. 20 at Central Christian Church, 1111 W. Broadway, Enid, Oklahoma”

Survivor Encourages Early Lung Cancer Screening
REDWOOD CITY, CA – “You may be surprised to know that lung cancer is the number one cancer killer in the United States, according to the National Cancer Institute. People do not like to talk about it because there is a stigma associated with smoking, but lung cancer is also striking down more non-smokers. We talked to a lung cancer survivor whose family is using every tool available to save lives.”

Lung Cancer Alliance-California Issues Inaugural State-Specific Report Card on Lung Cancer
“Today, Lung Cancer Alliance-CA (LCA-CA) issued its 1st annual Report Card on Lung Cancer in the state of California and gave failing grades to the state for its lack of progress in reducing lung cancer mortality which claims more lives in California each year than all other major cancer combined.”

Week Ending November 9, 2008

Detecting Lung Cancer Early Can Aid Treatment
“The Cleveland Clinic is launching a study involving cutting-edge technology that could hold a key to detecting lung cancer at an early stage when treatment is most effective. The three-year study, involving 8,000 patients, will analyze the effectiveness of using chest x-rays to detect abnormal changes in lung tissue caused by lung cancer in its early stage. The chest X-rays will be analyzed using computer-aided detection (CAD) software that can identify the changes.”

First-Ever Mapping of Cancer Patient's Genome
(HealthDay News) – “In a genetics first, researchers report that they have decoded the complete DNA sequence of a person with acute myelogenous leukemia.”

Studies Show Tarceva Slows Lung Cancer
“Another battle was recently won in the war against lung cancer. Shares of the company OSI Pharmaceuticals, Inc, are soaring as the company recently released the dramatic findings of their latest pharmaceutical study.”

Project Planned to Lower Cancer Numbers in Eastern Kentucky
“Eastern Kentucky leads the nation in lung cancer deaths, but one groups of cancer and health officials plans to get those numbers turned around, and a $3,000 grant will help get the project off the ground.”

Cigarette Smoking And Lung Cancer: A Deadly Mix, Especially For African-American Males
“Millions of people play the lottery. They walk into a grocery store, buy a ticket and wait for someone to announce the winning numbers. Millions of people also smoke—one in five American adults to be exact.”

Weekend Event Raises Money for Lung Cancer Treatment
Raleigh, N.C. — “Before she was diagnosed with lung cancer in September 2007, 40-year-old Melita Hunt thought she was as healthy as anybody she knew.”

Nonsmoker Who Survived Lung Cancer to be in Event
“Taylor Bell never imagined she would be a spokeswoman for the North Carolina Lung Cancer Partnership, but then, the 22-year-old college student also never imagined she would be a lung cancer survivor.”

Lung Cancer Leaves Victims Breathless
“November is National Lung Cancer Awareness Month. My mother died in August of this terrible disease. As a devoted daughter, I felt compelled to continue her battle against lung cancer, despite her death.”

Choctaw Teacher Dies of Cancer
“Choctawhatchee High School is mourning the loss of long-time reading teacher and literacy coach Sue Kruger, who lost her battle with cancer Saturday.”

Country Star Merle Haggard Recovering after Lung Cancer Surgery in Bakersfield
“At the insistence of his family and personal physician, Merle Haggard had a cancerous growth removed from his lung Monday at Bakersfield Memorial Hospital. Friends and associates of the country music icon said the surgery was a success and he is in stable condition.”

Piedmont Newnan 'Dessert and Discussion' on lung cancer treatment options
“Lung cancer is by far the leading cause of cancer death among both men and women, accounting for around 29 percent of all cancer deaths, according to the American Cancer Society.”

Week Ending November 2, 2008

Media Coverage of Lung Cancer Is Increasing - and Increasingly Negative, New Report Shows
“CancerCare today announced that despite an overall increase in news reporting on lung cancer, the overall tone of lung cancer media coverage has become significantly more negative. "How the U.S. Media Report on Cancer," an analysis of lung, breast, colorectal and prostate cancer coverage, was an independent report conducted by CARMA International Inc. for CancerCare; previous analyses were issued in 2000 and 2004.””

Highly Specialized, Minimally Invasive Surgery for Lung Cancer Allows Patient to Go Home Sooner Video-assisted thoracic surgery offers comprehensive cancer removal compared to open surgery
“Minimally-invasive surgery for lung cancer called video-assisted thoracic surgery or VATS is a relatively new procedure performed almost exclusively at academic centers. Now, a preliminary study to be presented this month at the annual CHEST meeting in Philadelphia is giving surgeons an early look at its benefits.”

Infinity Announces Expansion of Phase 2 Clinical Study Evaluating IPI-504 in Advanced Non-Small Cell Lung Cancer
“Infinity Pharmaceuticals, Inc., today announced that it has met pre-specified criteria to expand both arms of its ongoing Phase 2 clinical trial evaluating IPI-504 (retaspimycin hydrochloride), its lead heat shock protein 90 (Hsp90) inhibitor, in patients with advanced non-small cell lung cancer (NSCLC).”

Gene Variants Linked to Risk for Nicotine Dependence and Lung Cancer
(Reuters Health) – “A cluster of gene variants on chromosome 15 associated with lung cancer risk also appear to affect risk for nicotine dependence, epidemiologists at the University of Texas M. D. Anderson Cancer Center report.”

Guided Therapeutics, Inc. and Konica Minolta Extend Agreement to Expand Cancer Detection Technology
“Guided Therapeutics, Inc. (GT) and Konica Minolta Opto, Inc. (KMOT) of Tokyo, today announced that the two companies have extended an option to license and no shop agreement to co-develop certain of GT's non-invasive technologies.”

Vitamin E May Prevent Lung Cancer
“Researchers at the University of Texas Anderson Cancer Center found taking more vitamin E substantially reduces lung cancer (Int J Cancer.2008;123(5)1173-80). The new study shows people consuming the highest amounts of vitamin E had the greatest benefit.”

Gene Variants Linked to Risk for Nicotine Dependence and Lung Cancer
(Reuters Health) – “A cluster of gene variants on chromosome 15 associated with lung cancer risk also appear to affect risk for nicotine dependence, epidemiologists at the University of Texas M. D. Anderson Cancer Center report.”

Rockland Biomedical Company Turns Focus to Cancer
“Patients with the most common form of lung cancer had a median survival period of 31 months when given an experimental vaccine from EMD Serono, compared with 13 months for those who did not, in clinical trials.”

Allergies Could Ward off Cancers
“Allergies could be more than just a frustrating immune condition they may provide protection against a range of cancers. Researchers at New York's Cornell University have found allergies can help in the fight against cancer by expelling carcinogenic particles from the body.”

Olyphant Kindergartner's Next Project: Cure for Cancer
“Framed photos covered the long table in the dining room of Timmy Walsh earlier this month. A hobby photographer, Timmy was selling his photography of turtles, ducks, flags and other odds and ends to raise money for lung cancer research.”

Lungs 4 Life Benefits Lung Cancer Research
“There's a new sign taped to my computer, one with a quote I am trying to incorporate every day: "Just stop complaining and find a creative way to be part of the solution." read it in an article a while back, then promptly tore it out and stuffed it into a handbag that ended up way in the back of the closet.”

Cancer Project Soldiers On
Heather Saler, who started the LUNGevity walk, died in May.

“When Heather Saler was diagnosed with lung cancer in 2003, she was determined to do something about it. A nonsmoker, she was bothered by the stigma surrounding lung cancer victims, and frustrated when looking for a coherent, national movement dedicated to funding lung cancer research, such as the Susan G. Komen Foundation for breast cancer.”

Cancer Center Hosts Open House
“Some cancer patients spend hours each day getting radiation treatments, and for months at a time. Julianne Walsh, 63, of Dover knows this all too well.”

Savvy solution?
Doctors Say Earlier Detection Using CT Scans Could ‘Drastically Reduce’ Lung Cancer Deaths

“All she had was a bad feeling. A nagging, terrifying one that sent chills up her spine and just wouldn’t go away. A cigarette smoker for 36 years, Laura O’Connor, 58, of Cherokee County, had tried to quit “a bunch of times.” Willpower didn’t work.”

John Nash Resigns Positions at University Hospitals' Ireland Cancer Center
“The man who came to University Hospitals two years ago to oversee the planning and construction of a new cancer hospital has resigned.”

Frisco Man Races Marathon for a Lung Cancer Cure
“Most people buy flowers, create a memorial, or meet with friends and family to honor a loved one who has passed away. Frisco resident Scott Shollenberger is taking a less traditional approach: running a marathon.”

Cancer Survivors Feel Great, Look Good in Hollywood
Going face to face with cancer is a matter of meshing medical care with couture for women who brought fashion, style and positive attitudes to a recent fashion show.

“Recently, 20 women walked a runway like beauty queens in the face of cancer that last year killed 600,000 in the United States. In casual wear and evening gowns, perfect makeup and just-so hair, the otherwise ordinary Broward and Miami-Dade women showcased the spirit that makes them survivors Oct. 20 in the 15th Look Good Feel Better Fashion Show at Memorial Regional Hospital in Hollywood."


Week Ending October 26, 2008

Lung Cancer Gene Discovery A Sign of Cancer's Future
“Science is tackling gene-caused flaws, cancer stem cells, and earlier detection of tumors The hoary metaphor of the war on cancer, as overused as it may be, is as evocative as ever to describe our efforts to beat the disease that will claim nearly 566,000 American lives this year alone. So let's fall back on martial imagery to describe our current position: We now know the enemy far better than ever before. And that promises much more precise targets.”

Study Finds That Practice Makes Perfect in Lung Cancer Surgery
DURHAM, N.C. – “Patients operated on by surgeons who do not routinely remove cancer from the lungs may be at a higher risk for complications, according to a study conducted by researchers at Duke University Medical Center.”

Breaking Cancer's Gene Code
Understanding the genetic underpinnings of cancer is a giant step toward personalized medicine “Imagine cancer, 2040. A 45-year-old woman who has never smoked develops lung cancer, which today kills more people than any other kind. (By then, of course, cigarettes will have gone the way of the buggy whip, and lung cancer rates will be cut in half.)”

ImmunoCellular Therapeutics Granted Patents Covering Its Lead Monoclonal Antibody Cancer Product Candidate
“ImmunoCellular Therapeutics, Ltd., a biotechnology company, announced the issuance of two separate U.S. patents relating to the company’s monoclonal antibody therapeutics. Patents No. 7,435,415 and No. 7,435,554 are both entitled “Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC).””

Boehringer Enrolls Patients for Lung Cancer Study
“Boehringer Ingelheim has begun enrolling subjects in a Phase III study for its lung cancer treatment BIBW 2992. The LUX-Lung 1 study will determine the efficacy of the drug in lung cancer patients who have not responded to similar treatments such as gefitinib or erlotinib.”

Federal Cancer Panel Proposes 'Three Crucial Actions' To Reduce Cancer Illness and Deaths
“With cancer deaths projected to rise at the same time funding for cancer research is stagnating, the President's Cancer Panel issued a report today urging a three-pronged approach to the problem: better coordination of the cancer enterprise, timely access for all Americans to health care and disease-prevention measures, and ridding the nation of tobacco.”

Threshold Pharmaceuticals Presents Encouraging Additional Preliminary Findings From a Phase 1 Clinical Trial of TH-302 for Solid Tumors
“Threshold Pharmaceuticals, Inc. today announced two presentations on its clinical stage hypoxia-activated prodrug, TH-302. The first is the Boston Biotech R&D Conference held today at the Harvard Medical School in Boston. The second is the European Organisation for Research and Treatment of Cancer (EORTC) conference, being held October 21-24, 2008 in Geneva.”

Key Data Presented for Gemin X Programs at the 20th Annual ENA Symposium
“GMX1777 Demonstrates Potent Anti-Tumor Activity, Tolerable Safety Profile and Potential for Combination Therapy for Melanoma; Dose for Phase 2 Study Identified Obatoclax Study Provides Key Safety Data and Scientific Insights for Current Phase 1/2.”

Thallion's TLN-4601 Inhibits Mutated K-Ras Signaling in Cancer Cells
“Thallion Pharmaceuticals Inc. today announced that data presented by collaborators demonstrated TLN-4601 inhibits proliferation and signaling of mutated K-Ras expressing cancer cells. The research was conducted in the laboratories of Drs. Channing J. Der and Adrienne D. Cox, University of North Carolina at Chapel Hill, and presented today at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Geneva, Switzerland.”

CyberKnife System Achieves 38 Percent Growth in Extracranial Treatments During Fiscal Year 2008
“Accuray Incorporated a global leader in the field of radiosurgery, announced today that treatments of extracranial tumors using the CyberKnife(R) Robotic Radiosurgery System increased by 38 percent worldwide during the fiscal year ending June 30, 2008.”

Fernald Plant Workers Faced Danger from 2nd Source of Radon
“Workers at the Fernald uranium processing plant near Cincinnati were exposed to a second, possibly more dangerous source of radon, a new study has found. Researchers at the University of Cincinnati have identified six uranium-ore silos in the plant’s production area that they say that exposed 12 percent of the workers there to dangerously high levels of radon.”

Lung Cancer Support Group in Atlanta, GA
“The Joan Gaeta Lung Cancer Foundation is very happy to sponsor the Lung Cancer Support Group at Saint Joseph's Hospital in Atlanta.”

Cancer Patient Takes Legal Action Against NHS
“A lung cancer patient forced to pay for all her NHS treatment is taking legal action against the health service. Sue Bentley, from Usk, was forced to pay for all her NHS care – including chemotherapy – after she opted to pay for the drug Avastin privately.”

Community Prevention Resources of Warren County Promotes Lung Cancer Awareness
“Thousands of people will die from lung cancer this year. It kills more people than breast, prostate, colon, liver, melanoma, and kidney cancers combined.”

'Twisted Sisters' Taking up Fight Against Lung Cancer
WOONSOCKET — “Not to be confused with the New York City heavy metal band of the same name, the “Twisted Sisters” are four siblings from the Woonsocket area whose mission is to raise awareness and money in the fight against lung cancer.”

Week Ending October 19, 2008

Enzon Presents New Data On Its LNA Programs
BRIDGEWATER, N.J., October 20, 2008 -- Enzon Pharmaceuticals, Inc. presented data from its LNA technology platform at the 4th Annual Meeting of Oligonucleotide Therapeutics Society (OTS) in Boston, Massachusetts. “Our preclinical data reveals that our LNA-based Survivin antagonist safely down regulates the cancer target,” said Jeffrey H. Buchalter, chairman and chief executive officer of Enzon. “We are also encouraged by the data demonstrating enhanced delivery through the attachment of our customized PEGylation to LNA-based oligonucleotides.”

Celecoxib And The Drug Research Roller Coaster
In clinical trials, the arthritis drug showed promise in preventing cancer, but then it fell into the Vioxx controversy's wake. “The drug celecoxib (also known by its commercial name Celebrex) is often cited as an example of the mistrust and skepticism that has stunted research on many medicines with the potential to drive down individuals' cancer risks.”

Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage Of Bavituximab Phase II Lung Cancer Trial
Planned Cohort of 21 Patients with Non-Small Cell Lung Cancer Enrolled in First Stage of Trial Assessing Regimen of Bavituximab with Carboplatin and Paclitaxel

TUSTIN, Calif., Oct 20, 2008 -- Peregrine Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing monoclonal antibodies for cancer and serious viral infections, today announced that it has completed enrollment in the first stage of its Phase II trial evaluating a combination regimen of bavituximab with carboplatin and paclitaxel in patients with non-small cell lung cancer (NSCLC).

Personalized Cancer Therapies Are Out There, But They're Not Always Easy To Find
Internet research can lead patients to treatment options, which tailor therapies to specific cancers; but what they find may be cost-prohibitive.

“Personalized medicine and targeted cancer therapies are being offered at many academic medical centers and National Cancer Institute Comprehensive Cancer Centers. But many Americans who could benefit from personalized cancer care are not getting it.”

Scientists ID Virus That Infects Cancer Cells
TUESDAY, Oct. 14 (HealthDay News) – “New details about the structure of a virus that can infect lung cancer cells have been uncovered by researchers at the Scripps Research Institute in California.”

Infinity Initiates Phase 1 Trial Of Novel Hedgehog Pathway Inhibitor, IPI-926
Initiation Of Clinical Development Builds Upon Broad Potential Shown In Preclinical Studies

CAMBRIDGE, Mass., Oct 16, 2008 -- Infinity Pharmaceuticals, Inc., an innovative cancer drug discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its oral Hedgehog signaling pathway inhibitor, IPI-926, in patients with advanced and/or metastatic solid tumors.

Iressa® Confirmed Effective for Elderly with Non-Small Cell Lung Cancer
“Researchers from Japan have reported that Iressa® (gefitinib) is effective and well tolerated for initial treatment of elderly patients with non-small cell lung cancer (NSCLC). The details of this study were published in the October, 2008 issue of the Journal of Thoracic Oncology.”

Gtx Announces Investigational Ostarine(TM) (MK-2866) Met The Primary Endpoint In The Phase II Cancer Cachexia Clinical Trial
GTx, Inc. today announced topline results of a Phase II clinical trial evaluating Ostarine(TM) (MK-2866), an investigational selective androgen receptor modulator (SARM), in patients with cancer induced muscle loss, also known as cancer cachexia. In this analysis, the study met its primary endpoint of absolute change in total lean body mass (muscle) compared to placebo and the secondary endpoint of muscle function (performance) after 16 weeks of treatment.

Yale Cancer Center Identifies Genetic Marker to Predict Lung Cancer Risk
“Yale Cancer Center researchers have identified a genetic biomarker that may help to determine why some people are at an increased risk of developing lung cancer. The findings, published in the journal Cancer Research, could help identify smokers who should be carefully screened for lung cancer.”

Balloon Launch Nov. 1 To Remember Those With Lung Cancer
A Pickerington teacher who is living with lung cancer organized an upcoming event in honor of all those plagued by the disease. Mary Ann Kirkby, a seventh-grade social studies teacher at Ridgeview Junior High School, has played a key role in the creation of a balloon launch to be held at 11 a.m. Nov. 1 at Bloch Cancer Survivor's Park, at the corner of Lane Avenue and Olentangy River Road in Columbus. "It's designed to basically kick off the month of November, which is National Lung Cancer Awareness Month," Kirkby said.

Washington's First Run/Walk For Lung Cancer This Saturday
SEATTLE – “Lung cancer is the number one cancer killer in the United States. Yet, funding per lung cancer death is the lowest of them all. One woman is working to change that. It's estimated more than 4,000 Washington residents will be diagnosed with lung cancer this year and more than 3,000 will die. But there has never been a run or walk in Washington state to raise money and awareness for lung cancer - until now. The first one is happening in Tacoma this weekend.”

Corporate Angel Network Flies 30,000th Cancer Patient Flown To MD Anderson For Treatment For Lung Cancer
“Corporate Angel Network (CAN), the national public charity that provides free air transportation to treatment for cancer patients by using empty seats on corporate and fractional aircraft, announced Wednesday the flight of its 30,000th cancer patient. Liberty Mutual, a CAN supporter since 1991, flew Jennifer Aja-Thresher, a 54-year-old lung cancer patient from Atlanta, to Houston's MD Anderson Cancer Center where she will participate in a clinical trial.”

In Memorium

Rep. Paul G. Rogers, 87; Washington's 'Mr. Health'
“Paul G. Rogers, 87, a retired U.S. congressman known as "Mr. Health" for his work on environmental and health-care legislation during 24 years as a Democratic representative from West Palm Beach, Fla., died Oct. 13 at Sibley Memorial Hospital. He had lung cancer.”

Dawson Creek Mayor Dies Of Lung Cancer At 43
“Mayor Calvin Kruk of Dawson Creek, B.C., died of lung cancer Sunday at age 43. Kruk had been the mayor of the Peace region city since 2005.”

Week Ending October 12, 2008

Many Cancer Patients Forego Health Care Due To Soaring Cost Of Medication
(AHN) – “One in eight patients with advanced stages of cancers did not push through anymore with treatments because of the soaring cost of health care, according to a new study.”

Lung Cancer in Non-smokers a Separate Disease
(Reuters Health) – “Japanese investigators say that survival rates are better for patients with non-small cell lung cancer (NSCLC) who never smoked than in NSCLC patients with a history of smoking. Other disease characteristics are different as well between the two populations.”

Red Wine May Ward off Lung Cancer: Study
(Reuters Health) – “Drinking red wine, but not white wine, may reduce lung cancer risk, especially among current and ex-smokers, new research indicates.”

Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
“Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that the journal Cancer Research published results on efficacy of siRNA targeting its proprietary target gene against non-small cell lung cancer (NSCLC) in the edition dated October 1, 2008.”

Avastin-Tarceva Combo Fails in Lung Cancer Trial
“Genentech Inc. and OSI Pharmaceuticals Inc. said Monday a combination of two cancer drugs missed its primary goal in a clinical trial, failing to improve survival for patients with lung cancer.”

Cancer Institute Plans to Study Abraxis Drug
“The National Comprehensive Cancer Network said Tuesday it will conduct studies of Abraxis BioScience Inc.'s breast cancer injection Abraxane for other forms of the disease.”

Lung Cancer Benefit To Be Held For Deceased Business Leader
“Upstate runners and walkers will be able to participate in an event that will benefit thousands of people who have been diagnosed with lung cancer.”

Pink Ribbons Overshadow Deadlier Cancer
“With the abundance of pink ribbons everywhere, most everyone knows that October is Breast Cancer Awareness Month. The disease is pervasive: One in eight women in their lifetime will be diagnosed with breast cancer. But there is another cancer that is a greater threat to women's lives. Lung cancer is by far the leading cause of cancer deaths among both men and women, according to the National Cancer Institute.”

Teacher Not Letting Cancer Slow Her
“Getting a roomful of seventh-graders excited about ancient Mesopotamia isn't easy at 7:30 a.m. But MaryAnn Kirkby was doing just that on a recent morning in geography class at Ridgeview Junior High School in Pickerington.”

Cancer Groups Look for Common Ground as Competition for Research Funds Heats Up
“The economic slump is energizing competition among more than 1,000 groups fighting to influence federal cancer-research spending -- and raising concerns among some in Washington's cancer establishment about the competing demands of advocacy groups.”

Week Ending October 5, 2008

It Is Official: $20 Million for New Lung Cancer Research Now Law
“Tonight, the President signed into law funding for fiscal year 2009. Included in this omnibus measure is money to fund the Department of Defense and a new $20 million Lung Cancer Research Program.”

Alimta Gets OK for New Lung Cancer Use
“Eli Lilly and Co. on Monday said its Alimta injection was approved by U.S. regulators as a first-line treatment against lung cancer when used with a chemotherapy drug.”

Non-small Cell Lung Cancer - Pfizer Oncology Presents Safety and Efficacy Results Of CP-751,871 Study at ESMO 2008
“Pfizer announced updated safety and efficacy results surrounding its investigational compound, CP-751,871, in patients with non-small cell lung cancer (NSCLC). These results, along with supporting correlative science data, were presented at the 33rd European Society for Medical Oncology (ESMO) congress in Stockholm, Sweden.”

NCI Studying Biomarker Use in Lung Cancer Treatment
“The National Cancer Institute (NCI) has launched a 1,200-patient clinical trial to test whether biomarkers can be used to predict the clinical benefits of South San Francisco-based Genentech Inc.'s Tarceva (erlotinib) and Indianapolis-based Eli Lilly and Co.'s Alimta (pemetrexed) in patients with non-small-cell lung cancer (NSCLC).”

Survival in 1st-Line Non-Small Cell Lung Cancer (NSCLC) Significantly Prolonged By Erbitux(R)
“Data presented today at the 1st International Thoracic Oncology Congress Dresden (ITOCD) demonstrate that the addition of Erbitux® (cetuximab) to standard platinum-based chemotherapy in the 1st-line treatment of advanced NSCLC resulted in a significantly longer overall survival.”

Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' MiRview(TM) Squamous Assay
“Rosetta Genomics, Ltd., a leader in the development of microRNA-based diagnostic and therapeutic products, announced today the initiation of a clinical assessment study with the Johns Hopkins University School of Medicine. The study will compare Rosetta Genomics' miRview(TM) squamous, which differentiates squamous from non squamous non small cell lung cancer, with available immunohistochemistry methods.”


Week Ending September 28, 2008

OHSU Cancer Institute Researcher Combines Radiation Technology with Immunotherapy for Greater Effectiveness
“Oregon Health & Science University Cancer Institute researchers have found the right formula of radiation and immunotherapy for fighting lung cancer tumors in mice, which they hope will translate to better treatment in human lung cancers.”

Lung Fluid Test May Predict Lung Cancer Risk
“Testing lung fluid samples for levels of surfactant protein D (SP-D), which is thought to have a protective effect on the lungs, may help identify patients with a high risk of lung cancer, Canadian researchers report.”

For Newest Lung Cancer Drug Dispensed by Biologics, Inc.
“Biologics, Inc., the leading oncology management company, is pleased to announce that a new oral drug for the treatment of relapsed small cell lung cancer, Hycamtin (topotecan) Capsules, is now available through its oncology pharmacy.”

Doctors rarely respond with empathy, cancer study shows
“A little empathy goes a long way for cancer patients trying to cope with a poor prognosis, but doctors rarely offer it, a new study of recorded interactions shows.”

Massage May Relieve Pain, Improve Mood in Patients with Advanced Cancer
“Massage may have immediate beneficial effects on pain and mood in patients with advanced cancer, according to the results of a multisite, randomized trial reported in the September 16 issue of the Annals of Internal Medicine.”

Roswell Awarded $1.2M for Lung Cancer Study
“Roswell Park Cancer Institute has been awarded grants totaling $1.2 million for research studies on lung cancer.”

Senators Cochran (R-MS), Boxer (D-CA), Brownback (R-KS) and Vitter (R-LA) Add Their Support to Lung Cancer Mortality Reduction Act
“Today, Lung Cancer Alliance (LCA) commended the support of Senators Barbara Boxer (D-CA), Sam Brownback (R-KS), Thad Cochran (R-MS) and David Vitter (R-LA) as cosponsors of S.3187: The Lung Cancer Mortality Reduction Act.”

Congress Sets New Course for Lung Cancer Research; Approves $20 Million for New Defense Department Program
“Lung Cancer Alliance (LCA) announced today that Congress approved $20 million for a new lung cancer research program at the Department of Defense (DOD) -- a top LCA priority.”

Week Ending September 21, 2008

Avastin Slows Progression of Lung Cancer
(Reuters) - “The results of a study presented on Monday show that Avastin combined with gemcitabine-cisplatin chemotherapy improves the time lung cancer patients live without progression of the disease, according to Swiss drugmaker Roche. There was also a positive trend to extended survival.”

New Oral Drug Shrinks Lung Cancers Before Surgery, Researchers Report
(ScienceDaily) - “Pazopanib, a new oral angiogenesis inhibitor, has demonstrated interesting activity in difficult to treat non-small-cell lung cancer, US researchers report.”

Amrubicin Receives FDA Fast Track Designation For The Treatment Of Small Cell Lung Cancer After First-line Chemotherapy
“Celgene Corporation announced that Amrubicin has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy.”

An 'HIV-test' Equivalent For Early Detection Of Lung Cancer
(ScienceDaily) —“A team of researchers led by Fred Hutchinson Cancer Research Center reports online today in the Journal of Clinical Oncology the validation of a potential "HIV-test" equivalent for the early detection of lung cancer.”

Sancuso® Approved for Chemotherapy-induced Nausea and Vomiting
“The United States Food and Drug Administration (FDA) has approved Sancuso® (Granisetron Transdermal System) for the treatment of chemotherapy-induced nausea and vomiting (CINV).

National Early Detection Study Aims to Improve Lung Cancer Survival Rates
(Canada) - “The Terry Fox Research Institute (TFRI) and the Canadian Partnership Against Cancer announce the launch of a nationwide lung cancer detection study, involving 2,500 current and former smokers in seven cities across Canada. The study has the potential to revolutionize the detection and treatment of lung cancer, which remains Canada's leading cause of cancer deaths.”

Flower is Latest Hospital to Add to Cancer Care
“To help the hours pass while fighting metastasized lung cancer with chemotherapy, Toledoan Pam Bauman can gaze outside large windows into a flower garden, watch whatever she wants on television, or stretch out for a nap.”

Cancer-Surviving Artist Helps Boston's Homeless
“An 81-year-old artist who used to be homeless has survived lung cancer and says now it's time to give something back to the organization that keeps his off the streets.”

Cancer Taboo: The Navajo and Western Medicine
“Buck Navajo Jr. sits on a bed inside his hogan as afternoon light illuminates dust motes twirling in the air. His left arm suspended in a sling, the medicine man's free hand waves as he gently chides his granddaughter.”

Walk Returns to Help Fund Lung Cancer Research
“When John Cico started feeling dizzy, nauseous and had memory problems, he thought a brain tumor removed earlier was coming back, according to his daughter, Lisa Cico.”

Week Ending September 14, 2008

Important Updates to the NCCN Drugs & Biologics Compendium(TM) Non-Small Cell Lung Cancer
“The National Comprehensive Cancer Network (NCCN) announces important updates to the NCCN Drugs & Biologics Compendium(TM) Non-Small Cell Lung Cancer.”

New Approach Uses a Common Virus to Combat Deadly Lung Cancer
“Among the 5,000 studies being discussed by 30,000 oncologists at the 2008 meeting of the American Society of Clinical Oncology (ASCO), a great deal of buzz was generated over the discovery that a substantial subset of patients with non-small cell lung cancer (NSCLC) may not benefit from the most commonly prescribed therapies.”

CDC Counts 2.4 Million Tobacco-Linked Cancer Cases in Five Years
“Despite decades-long efforts to curtail its use, tobacco remains a serious health issue. A new study by the Centers for Disease Control and Prevention (CDC) reports some 2.4 million cases of tobacco-related cancers were diagnosed in the United States from 1999 to 2004, with lung and bronchial cancer accounting for almost half of these diagnoses.”

Among Nonsmokers, Lung Cancer is Deadlier for Men
“Men who have never smoked are more likely to die from lung cancer than women nonsmokers, researchers reported on Monday.”

Ky. Leads Nation in Lung Cancer
“Kentucky leads the nation in tobacco production and use. So it's not a surprise to Kristy Bolen of the Ashland-Boyd Health Department that Kentucky also leads the country in lung cancer rates in both men and women.”

FISH Technology Holds Promise for Early Detection of Lung Cancer
“Fluorescent in situ hybridization (FISH) analysis of bronchoscopic brush biopsies might be useful in identifying patients at high risk of developing lung cancer and diagnosing the disease at an earlier stage. Non-small cell lung cancer (NSCLC) commonly displays cytogenetically visible deletions on chromosome 3p, and chromosomal deletions of the 3p22.1 and 10q22.3 regions can be reliably detected by FISH in brush biopsies, researchers report in the September issue of the Journal of Thoracic Oncology.”

Why One Dumb Tumor Is Smarter Than 100 Oncologists
“This week’s story paints a fairly bleak picture of cancer therapy 37 years after the start of the war on cancer, but as I spoke to some of the nation’s leading oncologists about their memories of when they first entered the field, I was struck by two things: the real progress that has been made since 1971, and their remarkable ability to remain hopeful in the face of a disease that, 1,500 times a day (that's how many people in the U.S. will die of cancer every day this year), reminds them that cancer keeps winning far too many battles.”

Targeted Tarceva Use effective for Some Tumours
“Using OSI Pharmaceuticals Inc's Tarceva pill to target tumours carrying specific genetic mutations significantly extended the lives of some people with lung cancer, Spanish researchers said on Saturday.”

Looking for a Cancer Cure in All the Wrong places
“Many patients being treated for cancer hold an apparently unshakeable belief that the medical establishment must be suppressing cheap “natural” cancer treatments out of ignorance or greed. Some turn to websites that promote products such as shark liver oil or mistletoe, convinced by claims that such remedies can cure their cancer quickly and painlessly — unlike the regimen proposed by their oncologist or hematologist.”

''Bidi'' Smoking Increases Risk of Lung Cancer Substantially
(Reuters Health) – “Smokers of rolled tobacco are nearly four times more likely to develop lung cancer than non-smokers, researchers from India report.”

Cancer Takes Heavy Toll on Seattle Firefighters
“Dave Jacobs started fighting fires when he was 20. It was the only job he ever wanted. He battled brush fires in California, house fires in Oregon and fires of every kind in more than two decades with the Seattle Fire Department.”

People Can Trim Cancer Risks, Expert Says
“Alaska causes cancer. So do California, Kansas and New Jersey. So says University of Pittsburgh epidemiologist and environmental cancer expert Devra Davis, who spoke at UAA Thursday evening (and will deliver a free public lecture at noon today at the Providence Cancer Center).”

Stories Link Cancer Battles, Insurance Woes
“Jeanie Burch's diagnosis of lung cancer this summer came with an added stressor: Though she has medical insurance, she found out it wouldn't cover all her treatment costs.”

Foundation Gives $20 Million for Cancer Research Building
“The Nevada Cancer Institute, which recently laid off staff and said the worsening economy has hurt donations, got a big boost Saturday in the form of a $20 million pledge from the Engelstad Family Foundation.”

Julia Roberts and Dave Matthews Rock Out for Cancer Concert
Longtime friends Julia Roberts and Dave Matthews joined forces Wednesday night at the sold-out Stand Up For a Cure concert at Madison Square Garden to benefit lung cancer research.

Easing the Stigma of Disease
"When Lori Hope, 54, a six-year cancer survivor, first tells someone that she successfully battled lung cancer, she is invariably asked, "Did you smoke?""

Week Ending September 7, 2008

Moffitt Cancer Center Receives Prestigious SPORE Grant Worth More Than $10 Million
“The National Cancer Institute (NCI) has awarded Dr. Gerold Bepler, program leader for thoracic oncology at Moffitt Cancer Center, and his team a Specialized Programs of Research Excellence (SPORE) grant in lung cancer.”

UM Cancer Center Wins Prestigious Recognition
National Cancer Institute designation to make more research money available “The nine years and millions of dollars the University of Maryland spent to earn the National Cancer Institute’s recognition has finally paid off, officials said Wednesday.”

Creating Lung Cancer Risk Models for Specific Populations Refines Prediction
“Lung cancer risk prediction models are enhanced by taking into account risk factors by race and by measuring DNA repair capacity, according to research teams led by epidemiologists at The University of Texas M. D. Anderson Cancer Center in two complementary papers appearing in the September issue of Cancer Prevention Research.”

Blacks with Lung Disease Face Increased Cancer Risk
“A new lung cancer risk assessment designed specifically for black Americans suggests that chronic obstructive pulmonary disease (COPD) is a much greater lung cancer risk factor for blacks than for whites.”

Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
“Two leading cancer centers have carried out groundbreaking radiosurgery treatments for multiple brain metastases using new RapidArc radiotherapy technology from Varian Medical Systems.”

Simcere: Study Reaffirms Benefits of Cancer Drug
“Chinese drugmaker Simcere Pharmaceutical said Wednesday that interim results of its cancer drug Endu reinforced its safety when used alongside chemotherapy.”

Oncologists Use Lung Cancer Vaccine to Personalize Care
“University of Cincinnati (UC) oncologists are involved in one of the largest international cancer vaccine clinical trials to date aimed at reducing recurrence and improving life expectancy among early-stage lung cancer survivors.”

Dietary Vitamin E Intake Linked with Lung Cancer Risk Reductions
“A comparison of the effects of various forms of dietary vitamin E on lung cancer risk shows a strong independent relationship only for alpha-tocopherol, researchers report.”

Bethesda Center Offers Support for Those Affected by Cancer
“In December 2006, Sandra Marrott was diagnosed with ovarian cancer. Soon after she moved from her home in New Jersey to Chevy Chase, alone and battling the cancer and the chemotherapy she was undergoing to treat it.”

Lung Cancer Advocates 'Stand Up' to Number One Cancer Killer
Raleigh, NC – “Cancer is in the spotlight this week with the nationally televised “Stand up to Cancer” event, but lung cancer survivors in our state, including North Carolina representative and House Majority Leader, Hugh Holliman, stand up to cancer every day as they battle the number one cancer killer of men and women in this country.”


Week Ending August 24, 2008

Biomarkers Differentiated Lung Cancer, Nontumor Lung Pathologies
“Researchers at Saarland University in Germany have identified potential serum-based biomarkers that may detect lung cancer, and these biomarkers appear to differentiate between patients with lung cancer and patients with nontumor lung pathologies.”

Identification of Low Penetrance Alleles for Lung Cancer: The Genetic Lung Cancer Predisposition Study (GELCAPS)
“Part of the inherited risk to lung cancer is likely to include common, low risk alleles. The identification of this class of susceptibility is contingent on association-based analyses.”

Enzyme That Sensitizes Cells To Chemotherapeutics Could Also Be New Anti-cancer Target
(Medical News Today) “Researchers at Van Andel Institute (VAI) and Novartis Institutes for Biomedical Research have identified an important enzyme required for cancer cell survival. Lowering levels of the enzyme caused a wide variety of cancer cells to die, reduced proliferation of cancer cells, and sensitized cancer cells to commonly used chemotherapeutic agents, such as the drug Taxol.”

Imaging System Lets Doctors 'See' Cancer During Surgery
Fluorescent dyes light up diseased tissue on video monitors, helping spare healthy cells
(HealthDay News) “A new imaging system that highlights cancerous tissue makes it easier for surgeons to detect and remove tumors without harming surrounding healthy tissue, according to U.S. researchers.”

NovaRx Moves into Phase III with Cancer Vaccine Lucanix
“Hoping to repeat its Phase II success, privately held NovaRx Corp. launched a pivotal study of therapeutic vaccine Lucanix (belagenpumatucel-L) in non-small-cell lung cancer (NSCLC) patients under a special protocol assessment approved early this year.”

Freedom to Choose Welcomes New Research On Lung Cancer
“A new study by scientists at the Environmental Chemistry department at Louisiana State University concludes that a new form of air pollutant, created from the fine particle residues in automotive exhaust pipes, smokestacks and household chimneys, has been identified which replicates the damage to humans caused by cigarette smoke.”

Using Food to 'Beet' Cancer
“You have probably heard nutritionists advise people to "eat a rainbow" of fruits and vegetables every day to promote good health. Now, scientists at the University of Southern Maine are hoping to put that rainbow in a bottle to fight diseases, including cancer.”

Morton Plant North Bay Streamlines Lung Cancer Care
“A patient comes to his doctor with a persistent cough, shortness of breath, chest pain. The doctor suspects lung cancer.”

Chili's Meaghan Latone, 36, dies of lung cancer
“Meaghan Latone, 36, of Chili, who inspired strangers to create and participate in an April 5K run/walk to support lung cancer research, died Saturday of the disease.”

Local landscaper donates time for Fargo man diagnosed with cancer
“Jeff Stangler of south Fargo had big landscaping plans this summer. Then came a grim lung cancer diagnosis. While Jeff has been too weak to work, a local landscaping crew heard the story and spent today making one man's summer dream come true.”

Week Ending August 18, 2008

Antioxidants May Protect Smokers from Lung Cancer
“Smoking generates free radicals in the body, causing cell damage that can sometimes lead to cancer. A study found that smokers might protect themselves from developing lung cancer by eating foods that are rich in antioxidants called flavonoids.”

New Chemotherapy Combo Holds Promise for Lung Cancer
But expert notes research is still in early stages
“Preliminary research has produced promising findings regarding a possible alternative treatment for people with a common type of lung cancer. The new combination of chemotherapy drugs could eventually become another option for people with advanced non-small cell lung cancer, which is very difficult to treat, the Japanese researchers suggest.”

Early Test for Cancer Isn’t Always Best Course
“Sometimes what you don’t know might end up being better for you. For years patients have been told that early cancer detection saves lives. Find the cancer before the symptoms appear, the thinking goes, and you’ve got a better chance of beating the disease.”

Lack of Sunlight Found to Greatly Increase Risk of Lung Cancer
“A new study has found a correlation between higher rates of lung cancer and less exposure to sunlight. The study was conducted by researchers from the University of California at San Diego and published in the Journal of Epidemiology and Community Health.”

Improved Therapeutic Effectiveness by Combining Liposomal Honokiol with Cisplatin in Lung Cancer Model
“Background: Honokiol is a major bioactive compound extracted from Magnolia. The present study was designed to determine whether liposomal honokiol has the antitumor activity against human lung cancer as well as potentiates the antitumor activity of cisplatin in A549 lung cancer xenograft model, if so, to examine the possible mechanism in the phenomenon.”

Cancer Patients at Increased Risk of Suicide
“Cancer patients often think about ending their lives and their suicide rate is roughly twice that seen in the general population, according to the results of three studies appearing in the Journal of Clinical Oncology.”

Cancer No Laughing Matter, Unless You're a Comic with It
“At 58, Grace White had spent nearly a decade on the road performing "combat comedy" in such outliers of the known comedy constellation as an Idaho Falls roadhouse, grange halls in Montana and at the annual motorcycle rally in Sturgis, S.D., where half-naked people often rushed the stage. "Also completely naked people," she said recently, clarifying.”

Medical Flight Crashes in Massachusetts, Killing 3
“A plane chartered by a nonprofit organization that arranges free flights for ill people to treatment centers crashed in the parking lot of a shopping center Tuesday morning in Easton, Mass. A cancer patient, his wife and the pilot were killed, officials said.”

Former "Nightline" Executive Producer Leroy Sievers has Died at 53
“Leroy Sievers, who inspired thousands upon thousands with his "My Cancer" blog, has died at age 53. He passed away Friday at his home in Maryland. You can see a tribute to him at”

Smoking Diaries Author Dies of Cancer, age 71
“Simon Gray - the Highgate playwright and diarist best known for penning The Smoking Diaries and for his heavy smoking and drinking - has died aged 71.”

Week Ending August 10, 2008

Lung Cancer Studies Earn Prestigious Award
“Shahriyour Andaz, MD, FACS, FRCS, Director of Thoracic Oncology at South Nassau Communities Hospital, is the co-author of two studies that earned honors at the Brooklyn and Long Island Chapter of the American College of Surgeons Murry Friedman Surgical Resident Competition.”

Washington Univ. Prof Wins $728K Grant for Cancer Research
“The American Cancer Society has awarded a $728,000 grant to a Washington University in St. Louis professor for cancer research, the society said Friday. Amy McQueen is the newest of the 12 current grant recipients in the St. Louis area. Her grant brings the society's total investment in St. Louis to $7,885,500.”

Gene Test Leads To Targeted Cancer Treatment
“Colorado researchers are offering new hope to lung cancer patients. Lung cancer is one of the deadliest forms of cancer. When it's caught early it can be treated, but most patients are diagnosed in the later stages of the disease offering doctors few effective treatment options. Now research is showing an extra cancer drug given to certain patients is doubling their life span.”

FDA Reviewing Biomoda Submission for Cancer Screening Study
“Biomoda, Inc., a development stage medical diagnostics company, submitted to the FDA a pre-IDE (Investigational Device Exemption) protocol for a clinical study using Biomoda's proprietary assay for detection of early lung cancer in veterans. The New Mexico state legislature allocated more than $1.6 million over two years towards the study that will screen more than 2000 veterans.”

Gene Raises Risk of Lifetime Smoking Habit: Study
“For most people, the first experimental drags on a cigarette bring on nausea, coughing and other signals from the brain that say, "Turn back. This is a bad idea." But for some, they bring a wave of pleasure.”

ImClone Calls Bristol Offer Too Low
“Biotechnology company ImClone Systems Inc. said on Monday that a $60-per-share takeover bid from partner Bristol-Myers Squibb Co was too low, but it would hire financial advisers to help it study the unsolicited offer.”

Hospital to Start Support Group for Cancer Patients
NORTH CAROLINA – “Shirley Rogers remembers their faces: the woman whose husband was serving in Iraq; the man who intended to take his wife out for dinner that night.”

Free Cancer Program Grows to Year-Round Session
COLORADO - “Poudre Valley Hospital is expanding its free cancer support program to aid increasing numbers of cancer patients. The program, Sharing the Cancer Journey, will run year-round, an increase from its previous twice a year programming schedule.”

Cancer Care is Not Accessible for Many Santa Cruz County Residents
The doctor's assistant called a patient to remind her about her appointment, but the call just left the patient frustrated. The patient spoke Spanish. The doctor's assistant spoke English.

Golf Tournament Raises Money for Cancer Research
APALACHIN, N.Y. – “A virtual army of golf carts lined up at the Links at Hiawatha for the sixth annual "Friends of Michael" golf tournament, eighteen holes to benefit Upstate Medical University's lung cancer research.”

The 10% Solution: Augusta Woman Beats Lung Cancer
AUGUSTA -- A decade ago, Debbie Violette, of Augusta, was diagnosed with lung cancer and told she had a 10 percent chance of surviving the next two years.

Week Ending August 3, 2008

Therapeutic Vaccines Said to Hold Big Promise
“The new chief executive of GlaxoSmithKline said on Wednesday therapeutic vaccines used to treat cancer and other diseases could become a major product line for the world's second-largest drugmaker.”

UM Cancer Vaccine Deal Reached
“After a decade of research, the University of Miami has announced it's teaming up with a venture capital firm to start a company to develop a lung cancer vaccine that could have huge benefits for those suffering from the deadly disease -- if the vaccine makes it through a lengthy series of tests.”

Exercise Testing for Cancer Fails to Follow Guidelines
(HealthDay News) – “Exercise testing has become a common part of cancer care and research, but most tests aren't administered according to American Thoracic Society guidelines, say Duke University Medical Center researchers.”

Drug of Hope for Lung Cancer Patients
“A new treatment which combines conventional chemotherapy and a relatively new drug can slow down the progress of tumors and prolong the life expectancy of lung cancer patients by about eight months, according to the latest study. The First-line Asian Sequential Tarceva plus Chemotherapy Trial (FASTACT) looked into how Tarceva, when used with chemotherapy, prolonged the survival rate of stage 3 Asian lung cancer patients.”

Stand Up To Cancer
“Stand Up To Cancer is a unique joint mission involving the three television networks. They'll come together for a big fundraiser to raise awareness and money for cancer research.” Imagine a Day When Cancer Isn’t Such a Threatening Word “Dr. Arthur Frankel wants to speed up the process of getting new cancer treatments to the patient. The day will come when a patient with cancer can beat it with a pill - and that’s it. No chemotherapy. No surgery.”

Med BioGene’s LungExpress DX™ Co-Inventor Takes Home $5 Million Award
“Dr. Francis Shepherd, co-inventor of Med BioGene’s LungExpressDX™ was recently awarded the prestigious Premier of Ontario’s Summit Award for her efforts in the field of lung cancer research, most notably her longstanding international leadership in the development of innovative approaches for lung cancer treatment and management.”

'Healing Garden' Opens at Cancer Institute
“A new "healing garden" that will comfort cancer patients receiving treatment here has been dedicated in memory of a Springfield man who was always involved in the outdoors.”

Granby Woman Helps Cancer Patients Access Resources They Need
“I’m telling you, I’m one butt ugly bald woman,” Jody Archinal says with a laugh, standing in the Shear Design hair studio. Today she wears the whitish locks she calls her “Carol Channing” look.


Week Ending July 26, 2008

American Cancer Care Beats the Rest
“A major international study recently confirms that U.S. medicine bests the cancer treatment available to people in 30 other countries, says Dr. David Gratzer, a physician, senior fellow at the Manhattan Institute, and author of "The Cure: How Capitalism Can Save American Health Care" (Encounter Books, 2006).”

Granite Countertops A Health Threat?
“If you have granite countertops in your home, you might consider testing them for the amounts of radon gas they give off, experts say, due to the potential that those amounts are above levels considered safe.”

High Gas Prices Affect Cancer Patients
“There's been a lot of talk about pain at the pump as gas prices climb. But for some people, those high prices are contributing to real physical pain. Some cancer patients depend on volunteers to drive them to their radiation and chemotherapy treatments.”

Albany Woman Frets over Cost of Cancer Care
NEW YORK – “With $200,000 of medical bills incurred in just two months, Arline Collins is not looking forward to more than four years of cancer treatment and the expenses still ahead. Collins, 53, was diagnosed with small cell carcinoma, a form of lung cancer, during an emergency gall bladder surgery on March 30. Treatment began immediately.”

When Back Pain is Lung Cancer
“When a loved one is diagnosed with lung cancer, you suddenly see smokers everywhere. They are husbands and fathers, sisters and mothers. They are tweens and college students who don't know--and probably don’t care--that cigarette smoke contains more than 4,000 different chemicals, many of them proven carcinogens.”

Cancer Patient's Recovery Amazes Doctors
SCOTLAND – “A lung cancer patient in Edinburgh who was given just a few months to live has stunned doctors by going into remission. The unnamed patient, a 69-year-old female ex-smoker from the Lothians, developed lung cancer in 2006. She also suffered from Crohn's Disease, an unrelated disorder which causes an uncomfortable inflammation of the bowel, and doctors suggested removing her Crohn's medication while treating the cancer.”

Exercise Testing for Cancer Fails to Follow Guidelines
(HealthDay News) – “Exercise testing has become a common part of cancer care and research, but most tests aren't administered according to American Thoracic Society guidelines, say Duke University Medical Center researchers.”

Week Ending July 21, 2008

ASA404 Programme to Expand with New Pivotal Trial in Lung Cancer
“Antisoma plc today announced that its Tumour-Vascular Disrupting Agent, ASA404, will enter a second pivotal phase III trial this year. The ATTRACT-2 (Anti-vascular Targeted Therapy: Researching ASA404 in Cancer Treatment-2) trial will be conducted by Antisoma's partner, Novartis, and will evaluate ASA404 as a second-line treatment for non-small cell lung cancer (NSCLC).”

BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept Clinical Trial
“BioNumerik Pharmaceuticals, Inc. today announced that patients with adenocarcinoma (the most frequently occurring form of lung cancer) participating in a Phase II clinical trial of Tavocept(TM) showed a survival increase of approximately 198 days (6.5 months). The trial observations included an approximate 40% reduction in mortality for adenocarcinoma patients receiving Tavocept.”

KSU Researchers Discover Lung Cancer Biomarker
ARAB NEWS: RIYADH: “King Saud University yesterday announced the discovery of a new lung cancer biomarker by a team of scientists and students led by V. Masilamani of the College of Science.”

Magnolia Compound Hits Elusive Target in Cancer Cells
ScienceDaily — “A natural compound from magnolia cones blocks a pathway for cancer growth that was previously considered "undruggable," researchers have found.”

Cancer Survivors Help Each Other to Live Stronger
“Radine Cox's story is hers alone, but in a way, the 58-year-old Decatur woman's tale echoes the experiences of countless others.”

Lung Cancer Benefit at Palaia Vineyards
“Palaia Vineyards is hosting a Neil Young Tribute Festival to benefit Joan’s Legacy against Lung Cancer on July 26 and 27 beginning at noon.”

Week Ending July 13, 2008

Cancer Death Rate Drop Tied to Education Levels
WASHINGTON (Reuters) – “Declines in death rates from the four leading types of cancer in the United States since the early 1990s have been driven largely by progress among college-educated men and women, researchers said on Tuesday.”

Women Smokers Not at Greater Risk for Lung Cancer than Male Smokers
( – “Women smokers may not be at greater risk for lung cancer than their male counterparts. These results were recently published in Lancet Oncology.”

Medicare Changes Don't Affect Cancer Care: Study
WASHINGTON (Reuters) – “Legislation that cut fees doctors receive for giving chemotherapy to Medicare patients has not affected care so far, researchers reported on Tuesday.”

Pricey Drugs Put Squeeze on Doctors
“Long a burden for patients, hyperexpensive cancer drugs are causing economic havoc for another constituency in U.S. health care: doctors.”

Gum Disease Linked to Cancer
“Gum disease has recently been linked to cancer. According to a research study published in the June issue of The Lancet Oncology, “Periodontal disease was associated with a small, but significant, increase in overall cancer risk.” Study results suggested that periodontal disease may either be “a marker of a susceptible immune system” or a direct cause of cancer.”

Nanotech Revives a Cancer Drug
A new formulation could bring a promising drug back to the clinic.
“In the 1990s, a cancer drug called TNP-470 dramatically increased life span for some patients and led to complete cancer regression in others. But when neurotoxicity was detected in some patients, clinical trials were halted.”

Single Gene Linked to Smoking Addiction and Lung Cancer
“Scientists have just discovered one more tool to use in the ongoing fight against the addictiveness and danger of smoking.”

Local Ladies to Log Miles for Cancer Research
(Massachusetts) – “In less than a month, Jennifer Gregg of Williston and Dawn Shackleton of Winooski will be riding in the Pan- Massachusetts Challenge to raise money for cancer care and research at Dana-Farber Cancer Institute through the Jimmy Fund.”

Leroy Sievers, Elizabeth Edwards: Life With Cancer
“Emmy award-winning broadcast journalist Leroy Sievers covered wars and ethnic conflicts in more than a dozen countries. He was diagnosed with colon cancer in 2002, had surgery and was clean for four years. Then doctors found a brain tumor and lung cancer.”

Week Ending July 6, 2008

Test Could Lead to Better Cancer Treatment
“Boston researchers have developed a test that can identify minute amounts of tumor cells floating in the blood of cancer patients, a discovery that could lead to better treatments with fewer side effects.”

Costly Cancer Drug Avastin Brings Hope, Dilemma
“It took only an instant for 58-year-old Gailanne Reeh to go from the picture of health to death’s door. By chance, her doctor noticed a lump under her arm during a routine exam. It turned out to be advanced breast cancer.”

Promising Cancer Drug Developed From Accidental Fungus
“According to a group of U.S. researchers, a drug created from both a fungus that contaminated a lab experiment, and nanotechnology could be effective in fighting a broad range of cancers.”

Rear Adm. Philip J. Coady, Helped to Battle Lung Cancer
“In his quarters aboard the USS Kitty Hawk, Rear Adm. Philip J. Coady Jr. reminisced in 1993 about the long journey from growing up in Boston to commanding the U.S. Navy's 12-ship task force in the Persian Gulf.”

Benefit to Help Lung Cancer Research
“A lung cancer benefit for the nonprofit Addi’s Cure will be at 5:30 p.m. July 18 at the Knights of Columbus Hall.”

Battle against cancer turns spouse into makeshift author
“Author Barbara Howe doesn't consider herself a writer. But when her husband of 26 years was diagnosed with lung cancer in 2005, she sat down at the computer and started typing.”

Honoring a Wife, Mother by Aiding Cancer Research
“Two years. That's the gift of extra time Barbara Fogarty received because of the promising cancer treatment she received at the James P. Wilmot Cancer Center at Strong Memorial Hospital. Priceless.”


Week Ending June 29, 2008

Senators Chuck Hagel and Dianne Feinstein Make Lung Cancer Matter
“June 25, 2008 marks a revolutionary day in history for anybody who cares about Lung Cancer, the Number One Cancer Killer in this country. It's almost tantamount to July 4th, Independence Day, for Lung Cancer.”

Marine Organisms Could Hold the Secret to Reducing Cancer
“Kava-kava tea, which is drunk as a relaxant in the Pacific island nations, contains elements which are thought to inhibit the formation of certain types of the disease including lung cancer.”

CB1400, Patented By Canopus BioPharma, Prevents Tumor Growth And Enhances The Anti-Tumor Effects Of Cisplatin And Cetuximab (Erbitux)
“Canopus BioPharma, Inc., has confirmed the efficacy of its oncology candidate, CB1400, as a tumor reducing agent and has also demonstrated the synergistic effect of this drug in combination with both cisplatin and cetuximab (Erbitux) in two mice lung cancer models.”

Faulty DNA Repair Could Be A Risk Factor For Lung Cancer In Nonsmokers
(ScienceDaily)— “People who have never smoked but whose cells cannot efficiently repair environmental insults to DNA are at higher risk of developing lung cancer than those with effective genomic repair capability, according to researchers from the Department of Epidemiology at The University of Texas M. D. Anderson Cancer Center.”

Cuba Approves, Makes Available Lung Cancer Vaccine
HAVANA (Reuters) – “Cuban scientists said on Tuesday the first vaccine to extend lives of lung cancer patients has been approved by Cuban authorities for use and is available in the island's hospitals.”

Can A Natural Vitamin Help Slow Lung Cancer? Study Looks At Role Vitamin D May Play In Shielding Lungs From Tumors
“You can get Vitamin D from the sunlight on a warm sunny day, from drinking a cool glass of milk or from supplements at the store, but no matter how you get it, a healthy dose of Vitamin D may be doing more good than first thought. In the laboratory, scientists have discovered that high doses of this common vitamin may help slow or prevent the growth of cancer cells.”

LSUHSC Inventor Awarded Patent for New Procedure to Detect Cancer Spread
“Eugene A. Woltering, MD, FACS, The James D. Rives Professor of Surgery and Chief of the Sections of Surgical Oncology & Endocrine Surgery at LSU Health Sciences Center New Orleans, has been awarded a US Patent for a one-step method to rapidly identify "sentinel nodes;" the lymph nodes most likely to contain early metastasis from a primary cancer.”

Individualizing Cancer Therapies Using "Anatomolecular" Imaging
(redOrbit) - “Many of us remember the 1989 film Field of Dreams, starring Kevin Costner. In brief, the main character becomes convinced that a baseball field must be built on his failing farmland. Another character assures him that if he builds it, "they" will come. And come they did, not only within the storyline of the movie but, as a result of the movie's popularity, to the real field in Dyersville, IA.”

NCI Cancer Imaging Program Update
(redOrbit) – “The mission of the Cancer Imaging Program (CIP) of the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), is to promote and support: (1) cancer- related basic, translational, and clinical research in imaging sciences and technology; and (2) integration and application of these imaging discoveries and developments to the understanding of cancer biology and to the clinical management of cancer and cancer risk. In short, the goals are to use cancer imaging to visualize problems and direct solutions.”

Cancer Charity Celebrates Success With Office Move
“Liverpool’S flagship cancer research charity is moving to new premises later this year after outgrowing its present site. The Roy Castle Lung Cancer Foundation has been based in London Road for the past decade.”

Vanderbilt Shines at National Cancer Meet
“David Johnson, M.D., deputy director of Vanderbilt-Ingram Cancer Center, is starring in a new role for the cancer community. Johnson’s photo is featured in ads for a new national advocacy campaign by the American Society of Clinical Oncology (ASCO).”

Week Ending June 22, 2008

Rolling Petition Prompts Atlantans to Fight Cancer
“Loretta Mealing lost both parents to lung cancer and a sister to breast cancer, which also threatened her life more than 11 years ago.”

Teen's Book Benefits the Cancer Society - Survivors Tell Stories 'In Their Own Words'
“If good news travels fast, words of hope must move at the speed of light. At least that's what Murrysville teen Kelsey Barner found out when she began compiling her inspirational collection of cancer stories, "In Their Own Words."”

Speak Out About Cancer With Your Art
“As the old adage goes, a picture is worth a thousand words. But for Anne Wilson of Morganton, N.C., a photograph she took of her late daughter, Katherine, contains enough inspiration to tell a story with an infinite word count. The photo moved family and friends so much that Wilson entered the picture into the 2006 “Lilly Oncology on Canvas” art competition – and went on to win first place in the United States. The art competition, started in 2004 by Eli Lilly and Company, honors the journeys many face when confronted with a cancer diagnosis.”

Take Part in The Latest Cancer Study at Relay for Life
“Everyday Joes and Janes may think there’s nothing they can do to help prevent cancer in future generations, but they’re wrong. The American Cancer Society is inviting Massachusetts residents ages 30 to 65 to sign up for its Cancer Prevention Study-3 at Relay for Life of Greater Fall River on Friday, June 27, from 5 to 9 p.m. at Somerset High School.”

Epigenomics Successfully Completes Larger Clinical Study in Early Lung Cancer Detection
(BERLIN and SEATTLE) - Epigenomics AG, a molecular diagnostics company focusing on the development and commercialization of products for cancer detection based on DNA methylation, today announced that it successfully completed a larger clinical study in its lung cancer program. The study was run in close collaboration with Prof. Dr. Christian Witt and Dr. Bernd Schmidt at the Charite University Hospital in Berlin, Germany.”

Researchers Find Smoking-Lung Cancer Culprit
“A protein responsible for repairing damaged DNA may be a vital link to explaining how smoking causes lung cancer, U.S. researchers reported. Lung cells exposed to cigarette smoke produce less of the protein, called FANCD2, the team at Oregon Health & Science University Cancer Institute reported.”

Ability to Track Stem Cells in Tumors Could Advance Cancer Treatments
“Using noninvasive molecular imaging technology, a method has been developed to track the location and activity of mesenchymal stem cells (MSCs) in the tumors of living organisms, according to researchers at SNM's 55th Annual Meeting. This ability could lead to major advances in the use of stem cell therapies to treat cancer.”

EU Seeks Lung Cancer Caution on Pfizer's Exubera
“The European Medicines Agency said on Tuesday that information about lung cancer should be added to the label for Pfizer Inc's inhaled insulin drug Exubera, due to increased cases in patients taking the product.”

Lung Cancer Radiation Treatment Offers New Hope
“Lung cancer patients with little chance of survival have been offered new hope with a treatment that targets tumours in the lungs with radiation. People suffering from lung cancer or another form of cancer that has spread to the lungs are often not suitable for surgery meaning they have only a 20 to 30 per cent chance of living another three years.”

Oncothyreon Initiates Phase 1Trial of PX-866 Cancer Compound
“Bellevue-based Oncothyreon Inc. recently announced enrollment of the first patient in a Phase 1 trial of PX-866 in patients with advanced solid tumors. PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), an important cell survival signaling pathway.”

Patients with Lymphoma and CLL Are at Increased Risk of Lung Cancer
“Researchers from Wayne State University have reported that patients with Hodgkins lymphoma (HL), non-Hodgkins lymphoma (NHL), and chronic lymphocytic leukemia (CLL) have a 30-300% increased risk of developing lung cancer compared with controls without these diseases. The details of this study were reported at the 2008 meeting of the American Society of Clinical Oncology in Chicago, May 30-June 2.1”

Sydney Wins Lung Cancer Conference for 8000 delegates
“Sydney will take a lead role in the fight against lung cancer after a successful bid to host the World Conference on Lung Cancer for up to 8000 international experts in 2013.”

Week Ending June 15, 2008

Most Cancer Doctors Avoid Saying It's the End
“One look at Eileen Mulligan lying soberly on the exam table and Dr. John Marshall knew the time for the Big Talk had arrived. He began gently. The chemotherapy is not helping. The cancer is advanced. There are no good options left to try. It would be good to look into hospice care.”

President George W. Bush Names Waun Ki Hong, M.D., to National Cancer Advisory Board
“President George W. Bush today appointed world-renowned medical oncologist Waun Ki Hong, M.D., professor and head of the Division of Cancer Medicine at The University of Texas M. D. Anderson Cancer Center, to the National Cancer Advisory Board.”

Women Get Lung Cancer From Smoking at Same Rates as Men
(HealthDay News) – “Women who smoke are just as likely to get lung cancer as men who smoke, a large U.S. study found.”

CT Lung Cancer Screening No Cure-all For Smokers
(ScienceDaily) – “Screening for lung cancer with computed tomography (CT) may help reduce lung cancer deaths in current and former smokers, but it won't protect them from other causes of death associated with smoking, according to a new study.”

Inhalable Form Of Gene-therapy Takes Aim At Lung Cancer And Inflammatory Lung Disease
(ScienceDaily)- “A new inhalable form of gene therapy -- based on technology recognized in the 2006 Nobel medicine prize, shows increasing promise for treating lung cancer, infectious diseases and inflammatory lung disease, scientists have concluded after an exhaustive review of worldwide research on the topic.”

National Cancer Study Launched
(CANADA) - “Cancer agencies launched a massive new study yesterday that aims to track 300,000 Canadians over two or three decades, potentially generating valuable new data on what causes the disease.”

Roskamp Institute Wins Grant for Lung Cancer Research
“The Roskamp Institute was awarded a $100,000 grant for a project focused on stopping the growth of lung cancer. The small business technology transfer grant comes from the Florida Department of Health and James & Esther King Biomedical Research Program.”

Nicotine Addiction: Prevalence and Treatment
“A Seminar released on June 13, 2008 in The Lancet discusses nicotine addiction, and the potential for reducing its disease burden and death toll by improving public knowledge and using treatments individual to patients. This includes the potential creation of an antinicotine vaccine.”

Week Ending June 8, 2008

Cancer Survivors Cope With Long-Term Issues
“More than 12 million people in this country are cancer survivors, and most of those are learning to cope with long-term health issues they and their doctors never really addressed. CBS 2's Dr. Max Gomez explains one way survivors are dealing with this challenge together.”

Dream Round of Golf Becomes a Humbling Test
“The question was simple enough. Could a 10-handicap golfer shoot less than 100 on a golf course set up for a United States Open, under Open conditions with U.S.G.A. officials, NBC television cameras and a live gallery in tow?”

Ailing Paul Newman 'Suffering from Lung Cancer'
“Film legend Paul Newman is suffering from lung cancer, according to U.S. magazine reports. The Butch Cassidy and The Sundance Kid actor, 83, has been suffering from ill health for many months and in May was forced to pull out of directing a production of John Steinbeck's Of Mice And Men.”

More Profit Than Progress in Cancer Research
“As I do every year at this time, I have been covering the annual meeting of the American Society of Clinical Oncology, the world’s biggest gathering of cancer specialists. At least 33,000 medical professionals registered for this year’s meeting. The number of attendees has been climbing yearly for decades, an indication of the enormous growth of the cancer treatment industry.”

Rosetta Genomics And M. D. Anderson To Develop A MicroRN Based Diagnostic Test To Identify Risk Of Recurrence Of Lung Cancer
“Rosetta Genomics, Ltd., a leader in the development of microRNA-based diagnostic and therapeutic products, announced a research collaboration with The University of Texas M. D. Anderson Cancer Center and the Kleberg Center for Molecular Markers to develop a microRNA- based diagnostic test to predict risk of disease recurrence in lung cancer patients who have undergone curative resection.”

Pfizer/Avant's Brain Cancer Vaccine Shines at ASCO
“Pfizer has been demonstrating its credentials in cancer at the American Society of Clinical Oncology meeting in Chicago but the treatment that has most caught the eye is the brain cancer vaccine being developed by partner Avant Immunotherapeutics.”

ASCO: Little Support Seen for CT Lung Cancer Screening
“Controversy and lack of evidence for a mortality benefit have made physicians reluctant to embrace spiral computed tomography (CT) screening for lung cancer.”

Fruits, Vegetables, Teas May Cut Smokers' Cancer Risk
(HealthDay News) – “Eating fruits and vegetables rich in flavonoids and drinking tea may help protect smokers from lung cancer, say researchers from the University of California, Los Angeles (UCLA).”

VePesid®/Platinol® Remains Standard-of-care for Small Cell Lung Cancer
“For patients diagnosed with extensive-stage small-cell lung cancer (SCLC), the standard-of-care remains the chemotherapy combination of VePesid® (etoposide) and Platinol® (cisplatin). A recent study indicates that Camptosar® (irinotecan) plus Platinol does not improve survival in SCLC compared with VePesid/Platinol. These findings were presented at the 2008 annual meeting of the American Society of Clinical Oncology.”

Week Ending June 1, 2008

3 Network Anchors Team to ‘Stand Up to Cancer’
“NBC's “Nightly News” anchor Brian Williams, former TODAY co-host and anchor of CBS’ “Evening News” Katie Couric, and Charles Gibson, anchor of ABC's “World News Tonight,” announce a TV special to raise money for cancer.”

Lung Cancer Patients Fight Stigma "I'm sorry. You don't have breast cancer," the oncologist told Charmaine Atkenson. The 48-year-old mother of two had something far worse -- stage 4 lung cancer. It had spread to her spine, bursting the bone open. It was not only a sentence of death; it was a judgment.”

American Cancer Society, Patient Advocate Foundation Announce Free, Personalized Assistance for Cancer Patients
“The American Cancer Society and Patient Advocate Foundation today announced a strategic collaboration that will give millions of cancer patients and their families quick access to timely information and specialized patient assistance resources. This collaboration will help to improve the lives of cancer patients nationwide who are facing access to health care issues.”

Kate MacIntyre Foundation Goes Online To Broaden Advocacy for Lung Cancer Research and Education
“The Kate MacIntyre Foundation is proud to announce the launch of its website as it seeks to increase the awareness of lung cancer in non smokers. With the reach of this site, the foundation hopes to support lung cancer patient advocacy, encourage clinical research trials, mentor young professional women interested in a health care profession and raise money for this important efforts.”

Researchers Tapped Thomson Reuters Community of Cancer Patients for Studies To Be Reported at American Society of Clinical Oncology Conference
“Three studies to be reported at the American Society of Clinical Oncology (ASCO) Annual Meeting used Thomson Reuters Cancer Profiler tools to gain insights into the adverse effects of treatment for head and neck cancers and lung cancer.”

ASCO AT A GLANCE: Genetic Research A Focus Of Cancer Meeting
“Thousands of cancer specialists are in Chicago this week attending the 44th annual meeting of the American Society of Clinical Oncology, where pharmaceutical and biotech companies are providing updates on 4,200 studies. The five-day ASCO conference ends Tuesday.”

Lung Cancer Takes Center Stage at Conference
“Potential advances in the treatment of lung cancer, the leading cause of cancer deaths in the United States, will be a major focus at a key meeting of oncology specialists starting on Friday.”

Novartis, ImClone To Present Cancer Drug Data At Meeting
“ImClone Systems Inc., Novartis AG, Eli Lilly & Co. and Genentech Inc. (DNA) are among the drug companies set to showcase their efforts in the battle against cancer at a large medical meeting beginning Friday.”

Eli Lilly Says Phase III Trial of Cancer Drug Alimta Met Primary Endpoint
“Eli Lilly & Co. said Wednesday that its Phase III clinical trial of Alimta in non-small cell lung cancer patients met its primary endpoint of non-inferiority relative to overall survival.”

Gene Expression Profiling of Tumor is Correlated With Clinical Response
CHICAGO, May 30--“New data presented by GlaxoSmithKline today highlighted the potential of its investigational MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI) through results of three studies evaluating highly targeted immunotherapy as a treatment for metastatic melanoma and non-small cell lung cancer (NSCLC). These data were presented at the 2008 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago (Abstract Nos: 9065(1), 9045(2) and 7501(3)).

Erbitux Adds 5 Weeks to Lung Cancer Survival
”Lung cancer patients treated in a large clinical trial with ImClone Systems Inc's Erbitux and chemotherapy lived about five weeks longer than patients treated with chemotherapy alone, according to study results released on Saturday.”

Transgene says TG4010 Meets Primary Endpoint in Phase IIb Lung Cancer Trial
“French biotech company Transgene said the primary endpoint has been achieved in a Phase IIb trial evaluating its therapeutic vaccine TG4010 (MVA-MUC1-IL2) as an adjunct to first line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC).”

Enrolment Started For LUX-Lung 1 Study Oncology Research Programme
“Boehringer Ingelheim is making progress in its oncology research programme, particularly in the most common form of lung cancer, non-small cell lung cancer (NSCLC).”

Researchers Hail Anti-Cancer Advances but Lament Dip in Funds
“US researchers hailed promising advances in cancer treatment but lamented the decreasing amount of federal money devoted to finding a cure, ahead of the world's largest cancer conference this week.”


Week Ending May 26, 2008

Raising Cancer Awareness at Kites for a Cure 2008
“Say "Go fly a kite" in Southampton, and you're likely to get a friendly response. Some 500 families are expected to do that very thing tomorrow on Southampton's Coopers Beach. It's the second annual mass kite fly hosted by Joan's Legacy: United Against Lung Cancer.”

Kennedy, His Children, and Cancer
“Kara Kennedy was sitting in a doctor's office at Johns Hopkins Hospital with her father, Senator Edward M. Kennedy, when she got the news. Not only did she have cancer of the lung, it was inoperable. The doctor told her she might have less than a year to live.”

New Jersey Residents Aid Chief Battling Cancer
“Robert Reda has served the community with more than two decades of law enforcement, and now borough residents are coming together to help the police chief with mounting medical bills in his battle with lung cancer.”

Non-Smoker Diagnosed With Lung Cancer At 34
Greensboro, NC – “Cathy Rose says she went to the doctor for a cough, and a few weeks later she was diagnosed with stage four lung cancer."I would have never thought I could have gotten cancer at the age that I am, let alone lung cancer," said Rose, a 34-year-old with three small children. "Lung cancer is not just a smoker's cancer."”

ImClone Sees Lung Cancer Opportunity for Erbitux
&ldquoImClone Systems Inc., which will unveil lung cancer survival data for its blockbuster drug Erbitux next week, believes physicians will want to use the medicine for a substantial segment of patients.”

Final Hours, Days Eased For Lung Cancer Patients With Noninvasive Oxygen Therapy
“For patients with end-stage lung cancer, noninvasive ventilation (NIV) may be more effective at reducing breathing difficulty than standard oxygen therapy, and has the added advantage of reducing patients' reliance on morphine, thus improving lucidity in their final days, according to research presented at the American Thoracic Society's 2008 International Conference in Toronto on Tuesday, May 20.”

Cancer Drug May Help Patients with Heart-lung Disease
(ScienceDaily) “A drug developed to fight cancer is showing early promise as a treatment for pulmonary hypertension, researchers from the University of Chicago Medical Center report May 19 at the American Thoracic Society International Conference in Toronto, Canada.”

Tooth Loss Linked to Esophageal, Head and Neck, and Lung Cancer
“Studying thousands of patients, Japanese researchers have found a strong link between tooth loss and increased risk of three cancers – esophageal, head and neck, and lung. They suggest that preservation of teeth may decrease risk of developing these diseases.”

New Navigation System Offers Early Lung Cancer Detection
“This spring, Eisenhower Medical Center became the only hospital in Southern California, and one of only three locations in California, to offer superDimension's inReach system, providing the possibility to detect lung cancer early, even before symptoms are evident, and enhancing treatment options for patients.”

Lung Cancer: Lung Cancer Risks Genetic
“The recent study was published by researchers at John Hopkins University, as part of a multi-institutional study, collected DNA from 1,154 smokers who have lung cancer and 1,137 smokers without lung cancer.”

Week Ending May 18, 2008

Pilot Launched for Lung Cancer Screens
“A screening method tailored to pick up the country’s most lethal cancer early is being piloted in the UK. Currently, an adequate screening test for lung cancer is missing, and the UK's biggest cancer killer causes 33,000 deaths a year. Only 7 per cent of people diagnosed with lung cancer in the UK survive beyond five years. But early detection can boost survival in 80 per cent of cases.”

Lung Cancer Still Lowest in Federal Funding
”While lung cancer causes one in three cancer deaths, the National Cancer Institute (NCI: 20.86, -0.31, -1.46%) invested less than 5% of its $4.8 billion budget in lung cancer research in 2007, according to updated statistics issued by Lung Cancer Alliance (LCA) today.”

Potential Blood Test For Lung Cancer
(Medical News Today) “A simple blood test may be able to detect lung cancer in its earliest stages with unprecedented accuracy, according to new research to be presented at American Thoracic Society's 2008 International Conference in Toronto on Tuesday, May 20.”

Genetic Test For Lung Cancer Recurrence?
(Medical News Today) “The goal of developing reliable genetic tests to guide lung cancer treatment has taken a step forward. Researchers at Columbia University recently evaluated the ability of five high-risk genetic profiles, or signatures, to predict the likelihood that cancer would recur in patients whose non-small cell lung cancer was caught early and surgically removed. They will present their findings at the American Thoracic Society's 2008 International Conference in Toronto on Tuesday, May 20.”

New Pfizer Data In Lung Cancer, Ewing's Sarcoma, Prostate Cancer And Other Difficult-to-Treat Tumor Types To Be Presented At ASCO
“Pfizer announced that study results across several difficult-to-treat cancers will be presented at the 44th American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3, 2008.”

Week Ending May 11, 2008

Newsday Reporter Among 3 Honored by Suffolk group
“Lauren Terrazzano, a Newsday reporter who wrote about her own courageous battle with lung cancer as well as the region's most vulnerable populations, has been named Long Island Advocate of the Year by the Suffolk Community Council.”

Lung Cancer Survivor to Play on U.S. Open Course
“John Atkinson, a stage IV lung cancer survivor, has been selected to play as part of a celebrity foursome at Torrey Pines, the same course played by the pros at this year’s U.S. Open. Atkinson will play with NBC Today Show host Matt Lauer, Dallas Cowboys quarterback Tony Romo, and recording artist Justin Timberlake.”

Awareness May Reduce Minority Cancer Rates
“A cancer diagnosis can be a devastating blow for patients and their loved ones. I should know: I am a 10-year survivor of prostate cancer. And when my doctor told me I was facing the dreaded "c" word, no one was more surprised than me, my family and friends.”

Kaiser Health Disparities Report: A Weekly Look At Race, Ethnicity And Health
Science & Medicine
“Native Hawaiians, Maoris and Polynesians have higher rates of breast, stomach, cervical and lung cancer than whites, according to a study published in the May issue of The Lancet Oncology, the Honolulu Advertiser reports. The study examined the number of cancer cases, and survival and death rates among Polynesian populations in Hawaii, Easter Island and New Zealand, the Advertiser reports.”

Participants Needed for Indian River Cancer Study
“The Delaware Division of Public Health is encouraging residents of Sussex County to agree to participate in a health survey as part of research on lung cancer.”

Lung Cancer Care is Needed
“Results from recent research carried out by Macmillan Cancer Support showed a strong need for a lung cancer specialist nurse in the north Durham area.”

Cancer Latest: PLCO Screening Trial Do Prostate, Lung, Colorectal, Ovarian Cancer Screenings Really Make Difference?
“It was only a few years ago, that doctors found out screening and early detection made a difference in treating breast cancer patients. Now the University of Colorado Cancer Center is conducting a trial to see if that's the case for prostate, lung, colorectal, and ovarian (PLCO) cancer patients.”

Week Ending May 4, 2008

Caring Ambassadors Lung Cancer Program Launches Expanded, Redesigned Internet Site
“The Caring Ambassadors Lung Cancer Program (CAP Lung Cancer) proudly announces the launch of the CAP Lung Cancer Internet site redesign. CAP Lung Cancer is pleased to offer the community this state-of-the-art resource. The redesigned site is more user-friendly, and introduces many new features, and enhancements of existing tools and activities.”

Ultrasound Useful in Detecting Chest Wall Invasion by Lung Tumor
(Reuters Health) – “Ultrasound examination is more sensitive than CT scanning in assessing chest wall involvement in lung cancer patients, according to findings published in the April issue of Chest.”

Complete Thoracoscopic Lobectomy a Good Option for Lung Cancer Patients: Presented at ELCC
(Doctors Guide) - “Complete thoracoscopic lobectomy is a safe procedure that results in good recovery among patients and that has benefits for lung cancer patients that are impressive, researchers reported here at the 1st European Lung Cancer Conference (ELCC).”

Comparing Preoperative and Perioperative Chemotherapies: Presented at ELCC
(Doctors Guide) - “Two cycles of chemotherapy before surgery might be as effective as 4 in patients with operable stage I or stage II non-small-cell lung cancer (NSCLC), according to a study presented here at the 1st European Lung Cancer Conference (ELCC).”

Japanese Experience Favours Adjuvant Chemotherapy For Early-Stage Non-Small-Cell Lung Cancer: Presented at ELCC
(Doctors Guide) - “The success of the anticancer drug uracil-tegafur (UFT) in the postoperative treatment of early-stage non-small-cell lung cancer (NSCLC) has influenced Japanese clinical practice. Because of data showing that it extends the lives of patients with the disease, Japanese clinical practice guidelines now recommend adjuvant chemotherapy with UFT for patients with stage Ib disease and sometimes for those with stage Ia.”

Compugen Announces Discovery Of Blood Based Biomarker For Diagnosis Of Lung Cancer
(Medical News Today) - “Compugen Ltd. announced the discovery and experimental verification of CGEN-438, a potential blood based biomarker for lung cancer. CGEN-438 is novel splice variant peptide of delta-like protein 3 precursor (DLL3). Importantly, the Compugen discovered biomarker is a peptide that is secreted from the cell into the bloodstream, whereas the previously known DLL3 is a protein located on the cell membrane.”

Vicus Therapeutics Records Last Patient Visit Of Phase 2, VT-122 Trial For The Treatment Of Cachexia In Patients With Advanced Lung Cancer
(Medical News Today) - “Vicus Therapeutics, LLC, a biopharmaceutical company focused on oncology supportive care, announced today the completion of the last patient visit in its study VT1-CAX-001, a Phase 2 trial of VT-122. The compound was tested for the treatment of cachexia in weight losing subjects with Stage IV, non-small cell lung cancer (NSCLC).”

Aiding Development of a New Anti-Cancer Drug
“CSIRO has entered into an agreement with Adelaide-based biotech company, Oncaidia Ltd, to make the company's new anti-cancer drug, Apomab(R), suitable for human trials.
Oncaidia's Managing Director, Keith Smith, says Apomab has the potential to aid in the management of a number of human cancers that are currently difficult to treat - including prostate cancer and lung cancer.”

An Apple Peel a Day Could Keep Cancer at Bay
(NaturalNews) – “An apple peel a day might help keep cancer at bay, according to Rui Hai Liu, Cornell associate professor of food science, who has identified a dozen compounds -- triterpenoids -- in apple peel that either inhibit or kill cancer cells in laboratory cultures. Three of the compounds have not previously been described in the literature.”

AstraZeneca Submits EU Application for Gefitinib in Nonsmall Cell Lung Cancer
“AstraZeneca plc, the UK's second-biggest drugmaker, has submitted a marketing application to the European authorities for its oral anti-cancer drug gefitinib as a treatment for locally advanced pre-treated non-small cell lung cancer (NSLC).”

Cancer Death Rates Higher for Polynesians, Study Finds
“A new report showing higher cancer death rates for Native Hawaiians, Maoris and Polynesians throughout the Pacific Islands re-emphasizes the need for better cancer screening, data collection and health education in smaller countries, according to contributors to the study.”

Naza Group Founder and Chairman Dies of Lung Cancer in LA
“Founder and Chairman of the Naza Group, Tan Sri SM Nasimuddin SM Amin, died Thursday morning in Los Angeles, California, of lung cancer at the age of 53.””


Week Ending April 27, 2008

Scientists Address Lung Cancer Treatment
“Experts at a European conference in Geneva have been looking at ways of improving lung cancer treatment and contributing to patient survival. Lung cancer is recognised as the leading cause of cancer deaths, with some 1.3 million people diagnosed every year worldwide. In Switzerland, there are around 3,600 new cases and 3,000 deaths annually.”

Immune-Boosting Lung Cancer Therapy Shows Promise
“An immune-boosting treatment for lung cancer patients reduces the risk of cancer relapse after surgery to the same extent as chemotherapy but without the risk of unpleasant side effects, says a Phase II study by Belgian researchers.”

Thoracoscope and Mediastinoscope Together Yield Best Result for Minimally Invasive Radical Lymphadenectomies in Early-Stage Lung Carcinoma: Presented at ELCC
“Using a thoracoscope plus a mediastinoscope instead of a thoracoscope alone improves outcomes in patients with early-stage lung carcinoma undergoing minimally invasive radical lymphadenectomy without increasing morbidity, drainage time, or surgical time.”

Risk-Adapted 4-Dimensional Stereotactic Radiotherapy an Option for Stage I Lung Cancer: Presented at ELCC
“Stereotactic radiotherapy (SRT) is an "effective alternative" to surgery in patients with stage I non-small-cell lung cancer (NSCLC) who are either unfit for surgery or refuse surgery altogether, according to a study presented here at the 1st European Lung Cancer Conference (ELCC).”

Mutation Database Helps Personalized Treatment Of Lung Cancer
“A groundbreaking free tool to help oncologists choose the best therapies for patients with non-small-cell lung cancer has been just launched by scientists at the 1st European Lung Cancer Conference.”

Possible Viral Links to Lung Cancer Risk Uncovered
“Although smoking is well-established as an independent risk factor for lung cancer, two new studies suggest that two different viral infections might boost a smoker's already substantial risk for developing the disease.”

New Genetic Techniques To Combat Lung Cancer
“New results on genetic techniques that are helping doctors diagnose and treat lung cancer were released today at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, Switzerland.”

Columbia Prof. Discovers New Cancer Treatment
“Brent Stockwell, a Columbia biology and chemistry professor, has identified a potentially revolutionary new method to selectively kill cancer cells in humans. Stockwell, working with Columbia postdoctoral researcher Wan Seok Yang, discovered two new molecules called RSL3 and RSL5 that could be used to kill cancerous tumor cells while avoiding the harmful side effects of most existing cancer treatments.”

Week Ending April 20, 2008

Cancer Survivors Feel ‘The Obligation of the Cured’
“With the four survivors gathered in one room, the passion and urgency they exhibit is almost palpable. Each has his or her own unique story, and all are bound together by having faced the greatest struggle of their lives.”

Cancer Benefit for Valley Woman Set for April 26 at Copper Bar Downtown
Terre Haute, IN — “A benefit for Anita Hibschman is scheduled 2 to 4 p.m. April 26 in the Copper Bar at 810 Wabash Ave. Family and friends also plan a silent auction to raise funds for Hibschman, who recently was diagnosed with small cell cancer and faces a variety of costly treatments.”

Avastin Study Fails to Show Improved Lung Cancer Survival
“Biotechnology company Genentech Inc. said Monday updated results from a late-stage study show Avastin increased progression-free survival for lung cancer patients, but failed to improve overall survival rates.”

Biomarkers Allow Doctors To Match Therapy To Patient
(ScienceDaily) “Genetic variations ensure that no two people are exactly alike, nor are their cancers. Researchers now have the tools and the knowledge to predict how individuals will respond to cancer therapy, enabling more precise and effective treatment.”

Early Data on Amgen’s Anti-Angiogenesis Pipeline Molecules Suggest Biologic Activity Across Tumor Types
“Amgen, today announced results from preclinical studies suggesting a significantly greater reduction in tumor growth when AMG 386, a recombinant Fc-peptide fusion protein (peptibody) designed to bind angiopoietins 1 and 2, thereby inhibiting Tie2 dependent stimulation of endothelial cells, was combined with either of two vascular endothelial growth factor (VEGF) inhibitors -- bevacizumab or motesanib diphosphate (AMG 706) -- compared with either treatment alone (p< 0.05).”

Karmanos Cancer Institute Research Supports Role of Inflammation to Determine Lung Cancer Risk, Particularly in African-American Women
“Researchers at the Barbara Ann Karmanos Cancer Institute in Detroit today presented findings that support the role of inflammation in determining lung cancer risk, particularly among African-American women.”

Alfacell's ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment
“Alfacell Corporation today announced that Dr. Intae Lee with the University of Pennsylvania has reported that Alfacell's ONCONASE (ranpirnase) could be a promising radiation sensitizer for lung cancer treatment.”

Preclinical Data Highlighting Potential of Retaspimycin in Treating Non-Small Cell Lung Cancer With Acquired Drug Resistance Presented by Infinity and MedImmune At AACR
“Infinity Pharmaceuticals, Inc. and MedImmune today announced that preclinical studies evaluating lead drug candidate retaspimycin hydrochloride ("retaspimycin," also known as IPI-504), suggest that retaspimycin represents a novel strategy for the potential treatment of patients with non-small cell lung cancer (NSCLC) who exhibit resistance to Iressa(r) (gefitinib) or Tarceva(r) (erlotinib).”

Smoked Out: Funding Lung Cancer Screening Research with Tobacco Money
“A few weeks ago, we posted about conflicts of interest affecting a widely publicized study of using CT scans to screen for lung cancer. The study, basically a large case-series, was susceptible to multiple kinds of study bias that challenged its validity. Yet its authors used this limited and flawed data to strongly advocate such screening.”

Week Ending April 13, 2008

A Lung Cancer Survivor's Story
“When Bobbie Palmer of Yardley turned 50 last year, she went for a routine physical exam, expecting to learn that she had high cholesterol. Instead, she found out that she had advanced lung cancer.”

The 411 on Lung Cancer
“Lung cancer is the cancer that kills the most people in the U.S. An estimated 90,810 men and 71,030 women will die from it this year, according to the American Cancer Society.”

God, Family and Golf: How Charles Perry Defeated Lung Cancer
“When the Verizon Heritage rolled around last year, the rumbling voice of Charles Perry was silent. For the first time in 21 years, Perry was not there in his knickers, red coat and straw hat, announcing each player as he approached the 9th green.”

Judge Seals Portions of Lung Cancer Suit
“A federal judge yesterday sealed portions of a lawsuit that alleges the Hospital of the University of Pennsylvania and other parties should have known that the lungs they transplanted into a Newark, N.J., man were diseased.”

House Approves Study of Lung Cancer Among Miners
“The Minnesota House has approved a nearly $5 million study of Iron Range miners who have been hit disproportionately hard by a rare form of lung cancer. The bill passed today by an 88-45 vote. There's broad bipartisan support for conducting the study, but Democrats and Republicans are deeply divided over how to pay for it.”

Carrots Cut Cancer Risk by a Third
(NaturalNews) “Carrots are one of the most popular vegetables because they are easy to grow throughout the year in many climates, they can be eaten in a variety of ways, and they are incredibly delicious.”

Early Data on Amgen’s Anti-Angiogenesis Pipeline Molecules Suggest Biologic Activity Across Tumor Types
“Amgen, today announced results from preclinical studies suggesting a significantly greater reduction in tumor growth when AMG 386, a recombinant Fc-peptide fusion protein (peptibody) designed to bind angiopoietins 1 and 2, thereby inhibiting Tie2 dependent stimulation of endothelial cells, was combined with either of two vascular endothelial growth factor (VEGF) inhibitors -- bevacizumab or motesanib diphosphate (AMG 706) -- compared with either treatment alone (p< 0.05). Angiopoietins, together with VEGFs, are key cytokines that regulate neovascularization.”

Mouth May Tell The Tale Of Lung Damage Caused By Smoking
(ScienceDaily) — “Cells lining the mouth reflect the molecular damage that smoking does to the lining of the lungs, researchers at The University of Texas M. D. Anderson Cancer Center report today at the annual meeting of the American Association for Cancer Research.”

Cancer Gene Therapy Seminar Set
“The Alliance for Cancer Gene Therapy will host "The Promise of Cancer Gene Therapy for the Treatment of Lung Cancer," an April 16 seminar to explore advancements in treating lung cancer using gene therapy.”

Pfizer, Nektar Warn of Cancer After Insulin Powder
“Pfizer Inc. reported an increase of lung cancer among patients who used its discontinued inhaled insulin Exubera, another setback for developers of needle-free diabetes treatments.”

Abbott: No Lung-Cancer Signals In Inhaled-Insulin Trials
“Abbott Laboratories (ABT) has seen "no signals of lung cancer" in patient trials of its experimental inhaled insulin, a company spokesman said Thursday.”

Amrubicin Is Designated As An Orphan Medicinal Product By The European Commission For The Treatment Of Small Cell Lung Cancer
“Celgene International Sarl announced that amrubicin hydrochloride has been designated as an orphan medicinal product by the European Commission (EC) for the treatment of small cell lung cancer following the favorable opinion of the European Medicines Agency's (EMEA) Committee for Orphan Medicinal Products (COMP).”

Lilly Wins European Approval for Lung Cancer Drug
“Eli Lilly and Company has announced that the European health authorities have approved the use of Alimta for a histologically-based use in the first-line treatment of advanced non-small-cell lung cancer, the most common form of lung cancer.”

Allegro Diagnostics' Cancer Model Gets Into Peer-Reviewed Mag
“Allegro Diagnostics, a Boston developer of medical tests for cancer, reports its method for diagnosing lung cancer will be published in the first edition of Cancer Prevention Research.”

Novartis Corporation (NVS) Starts Phase III Lung Cancer Trial; Triggers $25M Milestone Payment to Antisoma PLC (ASM.L)
London, UK, and Princeton, NJ- “Cancer drug developer Antisoma announces that its partner Novartis has started the pivotal phase III trial of ASA404 combined with first-line chemotherapy in non-small cell lung cancer (NSCLC). The study, called ATTRACT-1, is designed to support applications for marketing authorisations in the US, Europe and other territories. Its initiation triggers a USD 25 million milestone payment to Antisoma.”

Poniard Pharmaceuticals' Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
“Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced that an analysis of data from its ongoing Phase 1 clinical trial of an oral formulation of picoplatin in patients with solid tumors showed that picoplatin can achieve oral bioavailability of up to 44 percent in doses tested to date.”

Week Ending April 6, 2008

Lung Cancer: My Genes Made Me Do It?
(Newsweek) — “How many scientists does it take to find a gene? If it’s a gene as important as one that raises your risk of lung cancer, at least 142—the number of researchers who conducted three separate studies being published today which all identify the same stretch of chromosome 15 as containing genes linked to lung cancer.”

New Method To Test For Lung Cancer Developed
(ScienceDaily) — “Researchers from Boston University School of Medicine have developed a new ‘clinicogenomic model’ to accurately test for lung cancer. The model combines a specific gene expression for lung cancer as well as clinical risk factors. These findings currently appear on-line in the journal Cancer Prevention Research.”

Lung Cancer Treatment Adds 2 years
WASHINGTON — “Radiofrequency ablation (RFA) -- an interventional treatment that "cooks" and kills lung cancer tumors with heat -- greatly improves survival time from primary or metastatic inoperable lung tumors, according to a study released at the Society of Interventional Radiology's 33rd Annual Scientific Meeting.”

Phase II results for CDP791 in Nonsmall Cell Lung Cancer Support Further Clinical Development
BRUSSELS, BELGIUM — “Results provide evidence of CDP791's biological activity. Positive trends were observed on several efficacy endpoints. Data are encouraging in supporting further clinical development of CDP791 in first line non-small cell lung cancer. UCB is evaluating partnership options.”

Columbia University and Rosetta Seek Approval for Cancer Test
“Rosetta Genomics and Columbia University Medical Center have announced that the first molecular test based on Rosetta Genomics's proprietary microRNA technology, developed by Columbia University, has been submitted for approval by the New York State Department of Health. The test is designed to differentiate squamous from non-squamous non-small cell lung cancer (NSCLC).”

New Conference Tackles The Tough Questions in Lung Cancer
GENEVA, SWITZERLAND – “Experts from around the world are gathering in Geneva next month at a new conference that aims to improve lung cancer treatment and answer unsolved questions about a disease that kills 1.5 million people each year.”

Tobacco Co. Funded Lung Cancer Study Elicits Mea Culpa from New England Journal of Medicine
“After embarrassing disclosures of financial links between the authors of a lung-cancer study and two large companies—General Electric and Vector Group, Ltd.—the New England Journal of Medicine published a correction, a clarification, and an editorial that called for the transparent disclosure of funding sources.”

Lung Cancer: A Deadly Diagnosis
“There is always hope, but the dismal truth is that the 5-year survival rate for lung cancer patients is 15 percent. More Floridians will die of lung cancer this year than breast, prostate and colon cancers combined.”

Lung Cancer: Drive it Off the Earth Golf Tournament III
“SAVE THE DATE, Monday, September 22, 2008 and join us this year at the private Lake Merced Golf and Country Club in Daly City, California to drive Lung Cancer Off the Earth. The 18-hole course features 6,863 yards of golf from the longest tees for a par of 72.”

A Screening That Would Save Lives
“She is angry, but who can blame her? Her sister - "my beloved sister" - died of lung cancer, writes a reader named Barbara. Her sister was diagnosed in April 2004 with lung cancer. She thought she had a cold. She died two years later.”

Buy Mother's Day Gifts, Support Lung Cancer Research
“Skip the typical Mother's Day gift basket this year and give your Mom beautiful jewelry that can make a difference. National Lung Cancer Partnership is offering a bracelet with matching earrings made of Swarovski crystals and two stylish lapel pins to help raise awareness and research funding for lung cancer, the number one cancer killer of women in the U.S.”

Gretna Cancer Patient Vies For Entry In Pro Golf Contest
OMAHA, Neb. – “A Gretna, Neb., man living with lung cancer has a unique chance to play golf at one of the toughest courses in the game.”

Scholarship Fund Set Up for Students in Families Affected by Cancer
“A scholarship fund for college-bound students has been established through CancerCare of Connecticut in the memory of the late Chet Arthur Smith, a Westport business executive who was imbued with a passion for learning.”

No Risk Factors, But They Got Cancer Anyway
“When making a diagnosis, doctors consider a patient's age, lifestyle choices and family history.”

Ten Things You Can Do to Reduce Your Cancer Risk
“Most people assume that cancer is genetic and cannot be avoided. However, according to the American Cancer Society, healthy behaviors could prevent approximately half of cancer deaths. Below is a list of 10 lifestyle changes, all based on the latest research, which people can make to improve their odds of preventing cancer or catching it at its earliest, most curable stages.”


Week Ending March 30, 2008

Cigarette Company Paid for Lung Cancer Study
“In October 2006, Dr. Claudia Henschke of Weill Cornell Medical College jolted the cancer world with a study saying that 80 percent of lung cancer deaths could be prevented through widespread use of CT scans.”

Did Big Tobacco Taint a Cancer Study?
“When cancer doctors read about the latest research findings in their journals, they expect two things — that the studies are scientifically sound, and that the results are not biased by any personal or institutional interests. But in a stunning revelation Wednesday, the latter expectation was apparently violated in a widely read lung cancer trial published in 2006 by researchers at Weill Cornell Medical College.”

Big Tobacco Funding for Cancer Research Decried
Revelation of Cigarette Maker's Role Troubles Doctors and Research Community

“A leading lung cancer researcher received funding from a tobacco company and failed to disclose the source of her funding in published studies, according to reports in two publications.”

Caring Ambassadors Lung Cancer Program Urges Support for Early Detection Research:
Funding Controversy Should Not Derail Efforts to Improve Lung Cancer Survival

VANCOUVER, WA – “Concerned about recent reports about funding from tobacco companies casting doubt upon the objectivity of past studies, the Caring Ambassadors Lung Cancer Program urges continued focus on critical early lung cancer detection research.”

UCB Considers Partner for Lung Cancer Drug CDP791; Reports 'Positive' Phase 2
BRUSSELS – “UCB SA. said it considering finding a partner for the development of its lung cancer drug CDP791 and reported 'positive' trends from second phase clinical trials.”

Nimotuzumab Boosts Effect of Ionizing Radiation Against Some NSCLCs
(Reuters Health) - Nimotuzumab enhances the antitumor activity of ionizing radiation in non-small-cell lung cancer (NSCLC) cell lines showing high or moderate expression of epidermal growth factor receptor (EGFR), according to a report in the February 26th issue of the British Journal of Cancer.

Celgene Brings in an Orphan
“Cancer drug giant Celgene announced yesterday that the FDA had granted its small cell lung cancer and breast cancer drug, Amrubicin, orphan designation for the treatment of small cell lung cancer.”

'World Wide Web of Cancer Research' Exploits Human Genome Map
“In June 2000, President Bill Clinton and British Prime Minister Tony Blair unveiled what amounted to a "rough draft" of the deciphered human genome, a milestone in the effort to crack the complex genetic code that shapes human development.”

Few Clinical Trials Focus on Alternative Approaches to Cancer
“The conventional paradigm that a viable treatment for cancer will come from a toxic synthesized drug and not an alternative non-toxic remedy is reflected in how our research dollars are spent.”

Hairdressers Could Face Increased Risk of Cancer: Study PARIS
(AFP) — “Hairdressers may face an increased risk of cancer because of the dyes and other chemicals they work with, according to the World Health Organisation's International Agency for Research on Cancer (IARC).”

Identical Genes From Parents May Raise Cancer Risk
(HealthDay News) – “People who have two identical copies of certain genes -- one inherited from the mother and one from the father -- seem to be at greater risk of developing a number of common types of cancer, research shows.”

Exposure To Low Levels Of Radon Appears To Reduce The Risk Of Lung Cancer
(ScienceDaily) — “Exposure to levels of radon gas typically found in 90 percent of American homes appears to reduce the risk of developing lung cancer by as much as 60 percent, according to a study published in the March issue of the journal Health Physics.”

Saving Cancer Patients' Skin For Later Dermatological Treatments
(ScienceDaily) — “Becky Sasaki has the quick laugh and easy smile of a woman who continues to thrive despite her four-year wrestling match with lung cancer. She still works every day in the family business, heads out for Thai food with her husband and baby sits for her energetic grandchildren.”

Neil Aspinall, Beatles Aide, Dies at 66
“Neil Aspinall, who left an accounting job to become the Beatles’ road manager when the group was still a local dance band and who went on to manage the band’s production and management company, Apple, died Sunday night in Manhattan. He was 66 and lived in Twickenham, England.”

Employees Aim for New Heights at Cancer Event
“The challenge of a 52-story climb will draw people from all walks of life, including several local Genentech employees, to San Francisco today.”

A Doctor’s Journey with Cancer
“When you suddenly learn you might have only 18 months to live, it’s a good time to sort out what really matters in life. Last December, Yang Chen, MD, dismissed an aching pain under his shoulder as muscle strain. Five weeks later, as the pain persisted, a chest x-ray brought shocking results: possible lung cancer that might have spread.”

Week Ending March 23, 2008

Antibodies May Point to Early Lung Cancer
“Lung cancer is usually diagnosed at a late stage when it's difficult to cure, but someday a blood test may lead to earlier detection, researchers report.”

First-Line EGFR Inhibition May Benefit Some Lung Cancer Patients
(Reuters Health) – “There is "strong evidence" that selected groups of patients with advanced non-small cell lung cancer (NSCLC) may benefit from first-line therapy with an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, according to the authors of a report in the March issue of the Journal of Thoracic Oncology.”

Lung Cancer Staging Completed with U/S Guided Approach
“A February issue of the Journal of the American Medical Association includes a report that validates use of minimally invasive approaches to stage lung cancer. A research team from the Mayo Clinic College of Medicine compared the diagnostic accuracy of three different approaches and combinations of those methods to determine the status of mediastinal lymph nodes.”

Nereus Pharmaceuticals Initiates Clinical Trial Of NPI-2358 In Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data
“Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from marine microbial sources, announced that enrollment has begun in a Phase 1b study evaluating the vascular disrupting agent (VDA) NPI-2358 in combination with standard chemotherapy in patients with non-small cell lung cancer (NSCLC).”

A MicroRNA Molecule Can Reduce Lung Cancer Growth, Study Shows
ScienceDaily (Mar. 23, 2008) — A small RNA molecule, known as let-7 microRNA (miRNA), substantially reduced cancer growth in multiple mouse models of lung cancer, according to work by researchers at Yale University and Asuragen, Inc., published in the journal Cell Cycle.

Treatment Gives Lung Cancer Patients With Inoperable Tumors Two Years Or More, Study Shows
(ScienceDaily) — “Radiofrequency ablation (RFA)—an interventional treatment that "cooks" and kills lung cancer tumors with heat—greatly improves survival time from primary or metastatic inoperable lung tumors, according to a new study.”

ArQule Begins Enrollment in Lung Cancer Trial
“ArQule has begun its Phase I/II clinical trial program of ARQ 197 administered in combination with Tarceva in patients with advanced nonsmall cell lung cancer (NSCLC).”

Detecting Lung Cancer
“This year alone, 200-thousand new cases of lung cancer will be diagnosed in the U-S. That used to mean a painful, invasive procedure. Now, there's a new technique that can provide important answers, sometimes within minutes.”

Winners Of Third Annual Research Grant Competition Announced By National Lung Cancer Partnership And LUNGevity Foundation
“The research grants, each $100,000, were created to advance research in basic lung cancer biology, risk assessment, prevention, detection, and response to treatment. "With the support of Genentech and our very generous donors, we’re able to offer researchers critical funding when choosing to investigate this deadly disease," said Regina Vidaver, executive director of National Lung Cancer Partnership.”

Winner Of 2007 Career Development Award Announced By National Lung Cancer Partnership
“National Lung Cancer Partnership is pleased to announce that Adam Marcus, Ph.D., of the Winship Cancer Institute at Emory University is the winner of the organization’s 2007 Career Development Award.”

The Promise Of Cancer Gene Therapy For The Treatment Of Lung Cancer Free Seminar April 16 Greenwich
GREENWICH, CT - “The Alliance for Cancer Gene Therapy is presenting a special seminar on The Promise of Cancer Gene Therapy for the Treatment of Lung Cancer with prominent cancer specialist Jack A. Roth, M.D., FACS.”

The War On Lung Cancer Needs Volunteers
“President Richard Nixon declared the war on cancer in 1971. Every day, 438 people die in this country from lung cancer. Twice as many women die from lung cancer than from breast cancer, and three times as many men die from lung cancer than from prostate cancer. Well, they are all old, smoked and knew the risk they were taking, you may think.”

Minimally Invasive Lung Cancer Surgery Available In Tucson
“It's a minimally invasive surgery that offers a quicker recovery with less pain than traditional surgery. Not only is it available here, but University Medical Center is a national training site for the surgery.”

Bone and Cancer Foundation Announces New Online Resource for Patients and Health Professionals
“The Bone and Cancer Foundation announced today the launch of a new online resource for the 400,000 patients whose cancers spread to their bones.”

Lung Cancer Program Gets New Medical Director
“Hoag Memorial Hospital Presbyterian has appointed Richard Fischel, the president-elect of the American Lung Assn. of Orange County, as the medical director of its lung cancer program.”

Exercise Program Helps Cancer Patients
SAVANNAH, GA - “Jan Callen knows what it means to be a survivor. Diagnosed with lung cancer more than a year ago, she's gone through chemotherapy and radiation. But the treatments to save her life, left her exhausted. "There were days I just really didn't want to get out of bed," she remembered. "I'm a high energy person and I couldn't stand that."”

Week Ending March 17, 2008

Lung Cancer Guidelines Withhold Endorsement of Computer-Assisted Tomography Screening: Presented at NCCN
“Support of computer-assisted tomography (CT) screening for lung cancer in high-risk groups is being withheld by the Non-Small-Cell Lung Cancer (NSCLC) Guidelines Committee of the National Comprehensive Cancer Network (NCCN).”

Risk of Surgery for Lung Cancer Is Lower at Teaching Hospitals
“Patients cared for by hospitals with residents in training have a 17 percent less chance of dying after lung cancer surgery compared with patients undergoing surgery at nonteaching hospitals, according to results of a Johns Hopkins study published in the March issue of the Annals of Thoracic Surgery.”

AstraZeneca Completes Enrollment In Two Late Stage Cancer Studies
“AstraZeneca announced that it has completed patient enrollment in two pivotal Phase III studies for vandetanib, the company's investigational, once-daily oral anti-cancer drug, for the second-line treatment of non-small cell lung cancer, NSCLC.”

FDA Cancer Czar Stirs Debate On Agency's Role
“Over two decades as an oncologist, Richard Pazdur frequently delivered bad news to patients. Once, a dying man grabbed his coat and begged him to try even more chemotherapy. The doctor says he declined, because he believed further treatment wouldn't help. The patient died less than an hour later.”

FDA Panel Gives Surprise OK to Amgen and J&J
“In a surprise decision, a panel of advisors for the Food and Drug Administration supported keeping anti-anemia drugs from Amgen and Johnson & Johnson on the market for use in cancer patients, according to Amgen.”

Telling Smokers How Old Their Lungs Are Works
“According to a study published by BMJ, smokers who were told their lung age were significantly more likely to quit than those who did not receive the information.”

Vermiculite Linked To Lung Damage, Even At Legal Exposure Levels
“Workers at a plant that processed vermiculite with asbestos-like fibers have scarring and thickening of the membrane that lines the chest walls, 25 years after the plant stopped using the material. In a study published in the American Journal of Respiratory and Critical Care Medicine, researchers show similar results even for workers who were exposed to the material - from a mine in Libby, Montana - at or below current legal levels.”

Frying Tumors Can Boost Lung Cancer Survival
“Needle-delivered frying or freezing technologies can be useful weapons against both lung and kidney cancers, new research shows.”

Lung Cancer Alliance Commends NCCN on Screening Guidelines
“Lung Cancer Alliance (LCA) called the new screening guidelines announced by the National Comprehensive Cancer Network (NCCN) "a positive step in the right direction that will encourage those at high risk for lung cancer to fully investigate their option of getting a CT scan.”

Cancer Studies Want You!
“Susan Stitt is sick of all the cancer. One neighbor has uterine cancer, another died of brain cancer. Stitt's mother has battled skin and breast cancer. A friend was recently diagnosed with colon cancer. Stitt could sit around feeling hopeless. Instead, she volunteered for the American Cancer Society's Cancer Prevention Study-3 (CPS-3), which is now recruiting participants nationwide.”

Coos County rates high for lung cancer, abuse and poverty
NORTH BEND, OR – “A new report shows Coos County still has high rates of lung cancer, child abuse and poverty when compared to all 36 counties in the state.”

Week Ending March 9, 2008

Cancer Funding: Does It Add Up?
“Should cancer spending be focused on the most common cancers? Or the most deadly cancers? That’s the dilemma for the cancer research community as it struggles to divvy up limited funds. After news yesterday that actor Patrick Swayze had been diagnosed with pancreatic cancer, several readers questioned the nation’s cancer funding priorities. I decided to look at the numbers.”

Biomarker Profile May Allow Tailored Treatment of Non-Small Cell Lung Cancer
(Reuters Health) – “Response to a regimen of celecoxib plus erlotinib is likely if a patient with non-small cell lung cancer (NSCLC) has low baseline levels of matrix metalloproteinase (MMP) and other biomarkers, researchers report in the February 1 issue of the Journal of Thoracic Oncology.”

Genentech to Work on Lung Cancer Drug Test
“Genentech Inc. will work with Abbott Laboratories and several other companies on a test to measure the effectiveness of the lung cancer drug Tarceva.”

Sutent® Has Activity in Patients with Advanced Non–Small Cell Lung Cancer
“Researchers involved in an international multicenter trial have reported that Sutent® (sunitinib) has significant single-agent activity in previously-treated, advanced non–small cell lung cancer (NSCLC). The details of this Phase II study were published in the February 1, 2008 issue of the Journal of Clinical Oncology.”

Surgery For Lung Cancer Holds Lower Risks At Teaching Hospitals
“Patients cared for by hospitals with residents in training have a 17 percent less chance of dying after lung cancer surgery compared with patients undergoing surgery at non-teaching hospitals, according to results of a Johns Hopkins study published in the March issue of the Annals of Thoracic Surgery.”

VATS Helps Some with Lung Cancer
Gainesville, FL – “It's called VATS, and for lung-cancer patients facing thoracic surgery, it can make a vast difference in the outcome.”

Study: Cutting Down on Cigarettes Cuts Lung Cancer Risk
“Not ready to quit smoking cold turkey? A new study shows that just cutting down on the number of cigarettes you smoke can reduce your risk of lung cancer.”

Doctors at Penn Medicine Symposium Praise Proton Radiation as a Cancer Treatment
“Sometimes it takes a really big machine to produce thousands of small miracles. Next year, a 220-ton particle accelerator — shipped from Belgium in January — will go online at the University of Pennsylvania's Abramson Cancer Center. When opened, the Roberts Proton Therapy Center will be the sixth such facility in the country, the only one in the mid-Atlantic region and the largest in the world.”

American Cancer Society Lauds Women for Fundraising Efforts
“Annapolis resident JoAnn DeCesaris and Elizabeth Prout Lennon of Friendship, both 31, go over details for the upcoming 6th annual DeCesaris/Prout Championship Golf Tournament which will be held June 27 at Twin Shields Golf Club in Dunkirk. The two founders of the newly formed DeCesaris-Prout Cancer Foundation have already donated $500,000 to charity.”

Allocation of $15.7 Million to Fund Quitline and Other Cancer Fighting Programs
“Attorney General Richard Blumenthal urged the legislature to allocate $15.7 million to the Connecticut Comprehensive Cancer Plan to restore the full services of the state’s Quitline and other vital tobacco cessation and education programs.”

Local Knitters Use Talents to Help Cancer Patients, Survivors
“Jacksonville resident Ann Kelley is throwing down the eyelash wool, left-handed purl-stitched gauntlet to anyone who’s ever tested a gauge.”

Wyoming Legislators Join Fight Against Cancer
CHEYENNE – “Half of all men and a third of all women will hear a doctor say: “You have cancer.” This statement used to be a death sentence. But new medications and procedures offer hope to patients fighting the disease. Wyoming’s lawmakers now have joined the battle. Last week they approved legislation to extend health insurance coverage to clinical trials.”

Week Ending March 3, 2008

A Deadly Disparity Uninsured Cancer Patients Get Later Diagnosis
“Treating health care as a commodity from which private businesses derive huge profits has produced a system that willingly allows uninsured Americans and minorities to suffer and die from treatable cancers at a much higher rate than white Americans who have health insurance.”

Study: More Complexity In Tailoring Cancer Drugs
“The genetic mutations in cancer cells may vary in every patient, a study found, suggesting that drugs will need to be tailored more finely to small groups.”

Smoking's Effects On Genes May Play A Role In Lung Cancer Development And Survival
ScienceDaily (Mar. 3, 2008) — “Smoking plays a role in lung cancer development and now scientists have shown that smoking also affects the way genes are expressed, leading to alterations in cell division and regulation of immune response. Notably, some of the changes in gene expression persisted in people who had quit smoking many years earlier.”

Biothera Drug Synergistic with Avastin(R) Against Cancer, Study Finds
“Biothera’s Imprime PGG™ increased the effectiveness of Avastin® (bevacizumab), a monoclonal antibody approved for the treatment of metastatic colorectal, breast and non-small cell lung cancer, according to a new preclinical study published in the current issue of Clinical Cancer Research.”

Oncothyreon Reports Promising Lung Cancer Drug
“Oncothyreon Inc. reported that a study of its PX-478 treatment for lung cancer in a test on mice “resulted in significant inhibition of tumor growth.””

Cancer Risk Up in Japanese Women Exposed to Smoke
NEW YORK (Reuters Health) – “The results of a study published in the International Journal of Cancer confirm that passive smoking is a risk factor for lung cancer, especially adenocarcinoma, among non-smoking Japanese women.”

AstraZeneca Stops Trial of Lung Cancer Drug• Toxicity Halts Testing of Tumour Treatment
“Recentin, a drug that aims to starve tumours by cutting off their blood supply, was being tested for non-small cell lung cancer - the most common form of lung cancer - in a trial in Canada.”

Most Cancer Patients Satisfied With Clinical Trial Experience
“While the majority of cancer clinical trial participants are highly satisfied with their experience, as few as one in 10 cancer survivors report ever being made aware of trial opportunities during treatment, according to a survey conducted by the Coalition of Cancer Cooperative Groups and Northwestern University.”

How Cigarette Smoke Causes Cancer: Study Points To New Treatments, Safer Tobacco
ScienceDaily (Mar. 1, 2008) — “Everyone has known for decades that that smoking can kill, but until now no one really understood how cigarette smoke causes healthy lung cells to become cancerous. Researchers from the University of California, Davis, show that hydrogen peroxide (or similar oxidants) in cigarette smoke is the culprit.”

Monticello Cancer Study Points to Uranium Mill
SALT LAKE CITY (AP) – “Monticello residents suffered from lung and stomach cancers at up to twice the normal rate over three decades, a possible legacy of a uranium mill near the town in southeastern Utah.”

Cancer Firefighters
“They were the young and the brave of West Palm Beach. They were the firefighters who went into a toxic warehouse fire, without wearing breathing equipment.”

Lung Cancer Concerns for Redland Shire
AUSTRALIA – “The Environmental Protection Agency has defended its practice of not doing independent air quality tests on quarries in the Redland shire. Scientists and an oncologist have raised concerns that thousands of people are at risk of developing lung cancer from silica dust from expanding quarries in the south-east Queensland shire.”

First European Lung Cancer Conference in Geneva, Switzerland
“The European Society for Medical Oncology (ESMO) is organizing the first European Lung Cancer Conference from 23 to 26 April in Geneva, Switzerland.”

Barbara Seaman Dies of Lung Cancer
“Barbara Seaman, a writer and patients' rights advocate who brought people' attention to the risks of oral contraceptives among other things, died from lung cancer on Wednesday at her home in Manhattan, the New York Times reported. She was 72.”

Lung Cancer Benefit Held For Keith Vandresar
New YORK - “A diagnosis of cancer and the financial hardships that follow can often add to the stress of battling the disease. For family and friends of Keith Vandresar, it is a fight that they are all in together. They gathered at Valentino's Restaurant in support of their friend Sunday.”

Despite Long Battle with Cancer, Jeff Healey's Death Still Shocking
TORONTO — “Acclaimed jazz and rock guitarist Jeff Healey was remembered Sunday as a musician of rare ability who had a wicked sense of humour and a generous nature as fans and bandmates mourned his death at age 41, following a battle with cancer.”

Nutrition is a Many-Splendored Thing
“At the farmers’ market, you’ll see the fresh fruits and vegetables spread out on tables to reflect the bounty of the season: blueberries, apricots, peaches, red cherries, summer squash, green beans, carrots, yellow and purple corn. The bright colors call out to you.”


Week Ending February 24, 2008

Protein Shines Light On Cancer Response
ScienceDaily (Feb. 24, 2008) — “A technique that specifically "tags" tumors responding to chemotherapy may offer a new strategy for determining a cancer treatment's effectiveness within days of starting treatment, according to a new study by Vanderbilt-Ingram Cancer Center investigators.”

EU Panel Recommends Alimta Use for Lung Cancer
NEW YORK, Feb 22 (Reuters) – “Eli Lilly and Co. on Friday said an advisory panel to European regulators has recommended that its Alimta drug be approved for the new use as a first-line treatment for advanced lung cancer.”

Expression Pathology Aids Research In Identifying Biomarkers Of Lung Cancer Metastasis And Survival
“Expression Pathology Inc. (EPI), a leader in tissue proteomics, announced that researchers at Tokyo Medical University, using the company's tissue microproteomics technologies, identified protein biomarkers associated with lung cancer metastasis, which were further studied for correlation to clinical outcomes. The researchers used EPI's Liquid Tissue® reagents and Director™ laser microdissection slides to analyze formalin-fixed paraffin-embedded (FFPE) tissue samples by mass spectrometry.”

Genzyme Genetics Works with British Firm on Lung Cancer Diagnostics
“Genzyme Genetics has signed an agreement with an English company that will bring a series of lung cancer tests to the global marketplace.”

Smoking’s Effects on Genes May Play a Role in Lung Cancer Development and Survival
“Smoking plays a role in lung cancer development, and now scientists have shown that smoking also affects the way genes are expressed, leading to alterations in cell division and regulation of immune response. Notably, some of the changes in gene expression persisted in people who had quit smoking many years earlier. These findings by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, appeared in the Feb. 20, 2008, issue of PLoS ONE.”

Announcement of National Lung Cancer Partnership
“The National Lung Cancer Partnership has announced that they are joining three distinguished organizations: the Lance Armstrong Foundation, the Oncology Nursing Society Foundation and the International Association for the Study of Lung Cancer in continuing the mission to increase opportunities for lung cancer researchers by co-sponsoring new lung cancer research grants.”

U.S. Cancer Death Rate Down but 565,650 Seen in 2008
WASHINGTON (Reuters) – “The U.S. death rate from cancer has continued a steady decline that began in the early 1990s but it will still kill a projected 565,650 Americans this year, the American Cancer Society said on Wednesday.”

Cancer and the Presidential Candidates
“Cancer is now the leading cause of death in adults under the age of 85. It is also the leading cause of death by disease in children. Every day more than 1,500 men, women and children die of cancer in the U.S. That is more than 1 person every minute. What do the current presidential candidates, Obama, Clinton, and McCain know about cancer? What do they plan to do to help put a halt to this outrageous death toll?”

Party for Mother to Benefit Lung Cancer
ATLANTA, GA - “Joan Gaeta's husband and their five kids threw her a party Saturday night. Her photos greeted guests by the front entrance. Tall vases with calla lilies graced the tables. The dance floor was ready for action. She would have loved it. Not long after the lifelong nonsmoker died at 68 from lung cancer in July, her family started talking about an event in her memory.”

Rolling With It
CLEARWATER, FL – “Julie Herring wanted to make a few extra bucks on the weekends. So she and a partner bought a limousine. Herring washed it, gassed it and drove friends around for a fee.”

Week Ending February 18, 2008

International Lung Cancer Conference, Liverpool - 9-12 July 2008
“From 9th - 12th July 2008, the new Arena and Convention Centre, Liverpool shall see the arrival of some of the world's leading lung cancer experts and will offer an opportunity to develop future strategies for early lung cancer detection, molecular diagnostics and therapeutics.”

Bayer Drops Drug From a Cancer Trial
“Bayer HealthCare Pharmaceuticals, a United States-based unit of the German pharmaceutical company Bayer, said on Monday that it had stopped a late-stage trial of Nexavar in patients with nonsmall-cell lung cancer after an independent data monitoring committee said it would not meet the main goal of improving overall survival.”

Scientists Solve Structure of Gene Regulator that Plays Key Role in Cancer
“Scientists at The Wistar Institute have collaborated on a major advance in understanding a gene regulator that contributes to some of the deadliest cancers in humans. The culmination of 10 years’ work, their research paves the way for the development of new cancer therapies.”

PET Outperforms CT for Diagnosis of Solitary Pulmonary Nodules
“Solitary pulmonary nodules that prove to be malignant are much more likely to be identified as such with positron emission tomography (PET) than with computed tomography (CT), a multicenter team reports in the February issue of the Journal of Nuclear Medicine.”

New Technology for Early Detection of Lung Cancer Selected for Clinical Study
“The New Mexico Institute of Mining and Technology (New Mexico Tech) and Biomoda, Inc., have partnered with the New Mexico Department of Veterans Services (DVS) to conduct a $350,000 clinical study using proprietary testing technology for detection of early lung cancer in the state's veterans.”

Boehringer Ingelheim's Lung Cancer Drug Gets FDA Fast Track Status
“Boehringer Ingelheim's investigational non-small cell lung cancer or NSCLC treatment BIBW 2992 has received fast track designation status from the FDA.”

Study Finds Cancer Diagnosis Linked to Insurance
“A nationwide study has found that the uninsured and those covered by Medicaid are more likely than those with private insurance to receive a diagnosis of cancer in late stages, often diminishing their chances of survival.”

Drug Research Hampered by Lack of Minority Participants
“Our bodies are not created equal. A particular lung cancer treatment can be riskier for people of Japanese ancestry. And there’s a new heart failure drug that helps African Americans more than other racial groups.”

Thailand Moves to Pay for Drugs to Avoid Sanctions
BANGKOK (Reuters) – “Thailand's new government could pay for four cancer drugs instead of overriding their international patents, Health Minister Chaiya Sasomsap said on Wednesday, fearing possible trade sanctions against his country.”

Vitamin and Mineral Use Widespread Among Cancer Patients
“Vitamin and mineral use is widespread among cancer patients and long-term cancer survivors, and frequently higher than among the general population.”

Judge Rules Casino Smoke Caused Dealer's Cancer
“A judge says years of breathing secondhand smoke in an Atlantic City casino gave a dealer lung cancer.”

Small Retail: It's the Inner Glow that Sells Handblown Glassybabys
“There’s something sensual and slightly improbable about glassybabys, the handblown, color-saturated tumblers that have become darlings of the design world. As round and fat as laughing Buddhas, they glow with striated color, especially when illuminated with votive candles. At $40 each, they have the kind of high-end simplicity a style maven like Martha Stewart might love. In fact, Stewart not only has a set, she commissioned her own color -- Bedford Brown -- and taped a TV segment about the Seattle company soon after her infamous prison stint in 2005. But it's their inner glow that makes them special to glassybaby founder Lee Rhodes, who drew comfort from their rich colors as she struggled with a rare form of lung cancer that struck when she was 32, with three small children.”

Week Ending February 10, 2008

First European Lung Cancer Conference April 23-28 2008, Geneva, Switzerland
Feb. 10 (Medical News Today) -- “Lung cancer is globally recognized as a big killer and it is undoubtedly a leading cause of cancer deaths in Europe and in the world. Researchers provide evidence of advancements which lead to continuous considerable improvements in possible treatments of lung cancer and offer valuable contributions to change the political and social environment for more pro-active prevention initiatives. Organized as a joint effort between the International Association for the Study of Lung Cancer (IASLC) and the European Society for Medical Oncology (ESMO), the European Lung Cancer Conference will be held biennially, alternating with the World Conference on Lung Cancer and the ESMO chest tumors conference. The event will gather top multidisciplinary experts to provide the audience (European and worldwide) with state-of-the-art education as well as with the most recent research data on both the most common and uncommon types of lung cancer.”

Less Invasive Way to Stage Lung Cancer Shows Promise
Feb. 5 (HealthDay News) – “Less invasive approaches for determining how far lung cancer has spread may be better than traditional, invasive procedures.
Although the finding, published in the Feb. 6 issue of theJournal of the American Medical Association, needs to be confirmed, it may point to a new era for people with lung cancer or suspected lung cancer.”

Anti-Cancer Jab [Vaccine] ‘Could be Available in a Few Years’
“A protective anti-cancer jab that can guard against recurrence of lung cancer after surgery has shown to be long lasting in tests and could be available within a few years.
The survival rate for lung cancer in Britain is dismal but now new hope is raised by a vaccine against a protein found in cancer cells that produces an anti tumour immune response.”

Salvage Surgery Feasible, Safe After Radiation for Lung Cancer: Presented at STS [Society of Thoracic Surgeons Annual Meeting]
“Salvage surgery after radiation in patients with recurrent non-small-cell lung cancer is feasible, safe and appears to have a relatively good long-term outcome.”

Good Long-Term Survival Seen with Stage T4 Lung Cancer Surgery: Presented at STS [Society of Thoracic Surgeons Annual Meeting]
“Select patients diagnosed with stage T4 non-small-cell lung cancer (NSCLC) can be successful candidates for surgery, even when the cancer affects structures outside the lungs.”

PET Outperforms CT In Characterization Of Lung Nodules, Study Shows
ScienceDaily (Feb. 7, 2008) — “Researchers involved in a large, multi-institutional study comparing the accuracy of positron emission tomography (PET) and computed tomography (CT) in the characterization of lung nodules found that PET was far more reliable in detecting whether or not a nodule was malignant.”

PhytoMedical Bolsters Cancer Research Following Favorable Results
“PhytoMedical Technologies, Inc. today announced that favorable research outcomes from ongoing tests have spurred immediate expansion of the Company’s cancer research program, actively working to develop patented, next-generation anticancer compounds targeting multiple human cancer strains.”

UK Lung Cancer Blood Test Licensed
“Lung cancer research from two University of Kentucky faculty members that has garnered worldwide attention is now moving an important step closer to the marketplace. Drs. Edward A. Hirschowitz and Li Zhong have spent the last five years working on a blood test that has been 90 percent accurate in correctly predicting non-small cell lung cancer in patients years before being detected by a CT scan.”

New Cancer Center at New York-Presbyterian/Weill Cornell
“New York-Presbyterian Hospital/Weill Cornell Medical Center has created an expanded cancer program dedicated to advancing research, prevention and treatment of the disease. The new Cancer Center is led by renowned cancer physician-scientist Dr. Andrew Dannenberg. A joint initiative of Weill Cornell Medical College and New York-Presbyterian Hospital, the Center will create strengthened and expanded research programs and multidisciplinary collaborations.”

Bon Jovi To Launch Cancer Benefit Concert Series
“Bon Jovi, Jerry Seinfeld, Brian Wilson and Andrea Bocelli, among others, will perform in various New York City venues throughout 2008 as part of the inaugural Stand Up For A Cure concert series, designed to raise funds and awareness for lung cancer research at the Memorial Sloan-Kettering Cancer Center in New York.”

Anne Francis: Actress Francis Battles Lung Cancer
“Veteran U.S. TV star Anne Francis has spoken out about her bid to beat cancer after having part of a lung cut out.”

Week Ending February 3, 2008

Biomarkers Found That Predict Lung Cancer Patient Response To Therapy
“Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.”

Smoking Sharply Increases Risk of Lung Cancer Among Breast Cancer Patients Treated with Radiation
“According to an article recently published in the Journal of Clinical Oncology, patients with breast cancer who received radiation therapy following a mastectomy have a significantly increased risk of developing lung cancer if they have ever smoked.”

Lung Cancer Surgery Improves Quality of Life
“Surgery for lung cancer can have a substantial impact on long-term, health-related quality of life, the results of a study published in the current issue of the Journal of Clinical Oncology suggest.”

Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer
“Quest PharmaTech Inc. today announced that it has signed a collaborative research agreement with the BC Cancer Agency (the "BCCA") to develop a combination therapy for the treatment of lung cancer.”

Oncothyreon Highlights Corporate and Clinical Objectives for 2008
“Oncothyreon Inc., a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today provided a review of the Company's clinical development plans and corporate objectives for 2008. Oncothyreon is developing both novel synthetic vaccines and targeted small molecules with the potential to improve the lives and outcomes of cancer patients.”

Perceptronix Medical Inc.: Kelowna Figures Prominently in Lung Cancer Research
“Perceptronix Medical Inc. was pleased to return to Kelowna, BC on January 24, 2008 to host a special meeting featuring the positive results of an international, multi-centre clinical study for lung cancer in which participants from Kelowna played a significant role.”

Healthy Lifestyle Crucial in Fighting Cancer
“Several recent studies show that lifestyle has a strong impact on the life expectancy of people with cancer. Here is a quick look at the eight recommendations the World Cancer Research Fund (WCRF) issued to improve quality of life and reduce the risk of relapse of cancer survivors.”

Lung Cancer Risk of One Marijuana Joint a Day Equals Daily Pack of Cigarettes
“Those who smoked the equivalent of one joint a day for 10 years had a 5.7 times higher lung cancer risk than nonsmokers even after adjusting for tobacco use, reported Richard Beasley, M.B.Ch.B., of the Medical Research Institute of New Zealand here, and colleagues in the Feb. 1 issue of the European Respiratory Journal.”

OU Team Finds Cancer Fighter
“Though years of testing remain, researchers hope it will one day be taken like a multivitamin. Oklahoma researchers have discovered a chemical compound that may one day become a pill that people can take daily to prevent cancer.”

Beverly Fund Fights Back Against Lung Cancer
“After her mother died of lung cancer in 2006, Traci Sestili channeled her grief into creating the Beverly Fund, a nonprofit dedicated to raising awareness about the disease.”

After Setback, Friends of Mel Forges On
“The Friends of Mel Foundation gift of $110,000 to The Wellness Community-Greater Boston to help fund its new Hanover center for cancer patients and families is a victory of sorts for the foundation.”

Redlands Cancer Study Probes Quarries
“A cancer specialist is reviewing cases of lung cancer around quarries in the Redlands after a study found the rate of cancer in the bayside region was higher than the average Queensland rate.”


Week Ending January 27, 2008

Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients with Non-Small Cell Lung Cancer
“Peregrine Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection, today announced that its Phase II clinical protocol to study bavituximab in combination with chemotherapy in patients with non-small cell lung cancer (NSCLC) has been approved by the Drug Controller General of India (DCGI).”

PhytoMedical’s Patented Anti-Cancer Compounds Kill Lung Cancer Cells, a Significant New Finding
“PhytoMedical Technologies, Inc., today announced that its patented bis-intercalator anti-cancer compound achieved a 50% or greater cancer cell kill rate in new in vitro studies of the DMS 114 strain of human small lung cancer cells, an important outcome given lung cancer’s high mortality rate and the lack of effective treatment options.”

Genzyme Announces License Agreement with Moffitt Cancer Centre
“Genzyme has announced that it has entered into a license agreement with Moffitt Cancer Centre to obtain exclusive worldwide diagnostic testing rights to the discovery of the relationship of two proteins to patient response to non-small cell lung cancer (NSCLC) treatment. The expression level of these proteins may help predict how these patients will respond to therapy.”

Serenex Announces Collaboration With National Cancer Institute to Evaluate Proprietary Small Molecule Hsp90 Inhibitors as a Potential Treatment for Lung Cancer
“Serenex, Inc., a leader in the discovery and development of small molecule Heat Shock Protein 90 (Hsp90) inhibitors, today announced the signing of a Materials Cooperative Research and Development Agreement (M-CRADA) with the National Cancer Institute (NCI) at the National Institutes of Health (NIH).”

NIH Nixes Knowing Outside Grantees’ Conflicts-of-Interest
“After admitting it routinely fails to collect and monitor university conflict-of-interest policies, the National Institutes of Health has rejected an inspector general recommendation that it collect detailed financial information from its extramural grantees and reveal what steps institutions are taking to manage, reduce, or eliminate any conflicts of interest.”

Cancer Gene Testing Service Launched by Lab21
“Lab21, a provider of health and environmental diagnostics, is providing a test for analysis of the K-ras gene from its Cambridge laboratories K-ras plays an important role in cell growth regulation and the proliferation of cancer cells.”

Marijuana Smokers Face Rapid Lung Destruction -- As Much As 20 Years Ahead Of Tobacco Smokers
ScienceDaily (Jan. 27, 2008) — “A new study finds that the development of bullous lung disease occurs in marijuana smokers approximately 20 years earlier than tobacco smokers.”

Smoking Ups Risk with Radiation for Breast Cancer
“Cigarette smoking dramatically increases the risk that a woman who has undergone radiation treatment for breast cancer will develop lung cancer later on, a new study shows.”

Royal Doctor Forced to Quit After Developing Lung Cancer 'Caused by Exposure to Asbestos'
“The Queen's trusted doctor has been forced to quit due to lung cancer. A trusted doctor to the Queen has been forced to quit after developing lung cancer, which he claims was caused by exposure to asbestos more than 40 years ago.”

Yeovil Doctors Involved in Cancer Tests
Yeovil, England, UK “Doctors based at Yeovil District Hospital are taking part in one of the world's largest lung cancer clinical trials investigating how a blood-thinning drug might help prevent blood clots in lung cancer patients.”

Australia: Big Rise in Lung Cancer
“Despite smoking rates falling to record lows, private health insurance claims for lung cancer have soared 21 per cent for women and 24 per cent for men in five years.”

Week Ending January 20, 2008

Cells That Promote Formation of Lethal Lung Metastases Identified
ScienceDaily (Jan. 15, 2008) — “Cancer patients usually ask what can be done after a primary tumor has already spread, or metastasized, to other organs. In many cases, they learn, little can be done. Hence the importance of a discovery by scientists at Cold Spring Harbor Laboratory (CSHL) of a type of cell that regulates the transformation of small, dormant lung metastases into large, aggressive metastases – the kind that kill cancer patients.”

Agennix Feceives FDA Nod for Phase III Lung Cancer Trial
“Agennix has reported that the FDA has approved the design of a single, pivotal, Phase III trial evaluating its lead molecule, talactoferrin alfa, in combination with chemotherapy as first-line treatment in patients with non-small cell lung cancer under the special protocol assessment process.”

Cysteine-Rich Protein Prevents Weight Loss In Lung Cancer Patients: A Promising Intervention Study
“Immunotec Inc. announced the successful completion of a multi-center randomized, double blind clinical trial on cancer-related weight loss (cachexia) in lung cancer patients which was performed in collaboration with various Canadian clinical centers(x).”

Lung Cancer Treatment Demonstrates Favorable Safety Profile
“French drugmaker Transgene reported data from a Phase IIb trial evaluating therapeutic vaccine TG4010 as an adjunct to first-line chemotherapy in patients with advanced nonsmall cell lung cancer. The randomized, open-label, controlled study assessed the efficacy of TG4010 in combination with chemotherapy (cisplatin and gemcitabine) compared with chemotherapy alone.”

New Mexico Veterans Call for State Funding of Early Lung Cancer Screening Using Biomoda Technology at 'Veterans' Day'
“Hundreds of State Veterans from seven organizations to converge on New Mexico State Capital and push for legislation to screen veterans for lung cancer.”

Moffitt Works With Genzyme On Cancer Test
“The H. Lee Moffitt Cancer Center & Research Institute is licensing a test for a type of lung cancer to Genzyme Corp. Their agreement calls for Genzyme to obtain from Moffitt exclusive worldwide diagnostic testing rights to the discovery of the relationships of two proteins to patient response to non-small cell lung cancer treatment, according to a release from Genzyme.”

Three Novel Approaches to Curing Cancer Win New Damon Runyon – Rachleff Innovation Award
“The Damon Runyon Cancer Research Foundation announced today that it has selected the first three recipients of its unique Damon Runyon – Rachleff Innovation Award modeled after venture capital investing to fund young scientists pursuing risky projects that have the potential to significantly impact the prevention, diagnosis and treatment of cancer.”

LabCorp to License Lung-Cancer Test From Duke
“Medical diagnostics company Laboratory Corporation of America said Thursday that it will license a new blood-based test for lung cancer detection from Duke University.”

Johnson & Johnson Licenses Cancer Test From 20/20
“A Rockville company has licensed its technology for a lung-cancer detection test to the diagnostics arm of pharmaceutical giant Johnson & Johnson.”

Veggie Lovers Could Fare Better in Cancer Fight
“If you're a middle-aged man (or already past it) here's what should be on your menu today: tomato sauce, watermelon, stir-fried tofu and veggies, selenium and vitamin E. Wash it all down with a swig of green tea or pomegranate juice and you may be able to ward off prostate cancer.”

Her Lung Cancer Tied To Radon
“She's never smoked, so Barbara Sorgatz was stunned to learn she had lung cancer. What probably caused the tumor, she later found out, was radioactive radon gas seeping into her home near Glen Ellyn.”

Week Ending January 13, 2008

Emphysema Detected by Low-Dose Chest CT Linked to Increased Lung Cancer Risk
“The presence of emphysema seen on low-radiation-dose CT images appears to be an independent risk factor for lung cancer, investigators report in the December issue of Chest.”

Exelixis Initiates Phase I/II Lung Cancer Trial
“Exelixis has initiated a Phase I/II trial of XL184 in patients with non-small cell lung cancer who have had progressive disease while on a regimen containing erlotinib.”

Possible Link Between Occupational Formaldehyde Exposure and Cancer
“According to the results of a review published in the Annals of Oncology, occupational exposure to formaldehyde may modestly increase the risk of brain tumors, leukemia, and lymphoma.”

No Change in Cancer Care 'Race Gap' Since 1990s
MONDAY, Jan. 7 (HealthDay News) – “Black cancer patients continue to be significantly less likely than white patients to receive treatment for lung, breast, colon and prostate cancers, new research finds.”

Improving Prognosis And Treatment Of Lung Cancer
ScienceDaily (Jan. 8, 2008) — “A group of scientists led by Professor Xavier Parés of the Department of Biochemistry and Molecular Biology at Universitat Autònoma de Barcelona, has published new research on AKR1B10, an enzyme that is detected in large quantities only in lung cancers, particularly those caused by smoking.”

Allos Therapeutics Initiates Phase 2b Study of PDX in Patients With Non-small Cell Lung Cancer
“Allos Therapeutics, Inc. today announced the initiation of patient enrollment in a Phase 2b, randomized, multi-center study comparing PDX (pralatrexate) and Tarceva (R) (erlotinib) in patients with Stage IIIB/IV non-small cell lung cancer (NSCLC) who are, or have been, cigarette smokers who have failed treatment with at least one prior platinum-based chemotherapy regimen.”

Statin Drugs May Cut Cancer Risk
“Study: Cancer May Be Rarer in People Taking Statins to Lower Their 'Bad' Cholesterol People taking cholesterol-lowering statin drugs may be less likely to develop cancer.”

Women Married to Smokers Have Increased Risk of Lung Cancer
“According to the results of a combined analysis of previously published studies, nonsmoking women married to men who smoke are more likely to develop lung cancer than nonsmoking women married to nonsmoking men. These results were published in the International Journal of Epidemiology.”

Women’s Risk of Lung Cancer Double That of Men
“A 10-year study using computed tomography (CT) screening found women had twice the risk of developing lung cancer from using tobacco that men did. This trial was part of a larger study, the Early Lung Cancer Project (ELCAP) in New York, which found annual CT screening for both men and women could more easily detect early tumors and reduce mortality rates than conventional screening methods.”

CMU Scientist Makes Cancer Cell Discovery
“Carnegie Mellon University scientist has discovered a combination of genes that make cells divide nonstop, resulting in cancer.”

ImClone Bets the Pharm on Erbitux
With crucial study results on cancer drug due in June, analysts wonder if one-product biotech's stock can add to last year's 65% gain. ImClone Systems has bet virtually everything on its only product, Erbitux, a cancer drug with a checkered history that helped to land its former CEO - and Martha Stewart - in prison.

CSHL Lung Cancer Research Program Awarded $100,000 Grant
“Cold Spring Harbor Laboratory’s (CSHL) researcher Raffaella Sordella, Ph.D. was awarded $100,000 by Joan’s Legacy: The Joan Scarangello Foundation to Conquer Lung Cancer. The two-year grant will fund CSHL’s pioneering lung cancer research involving a new class of genetic mutations that appear to be a trigger in non-small cell lung cancer, the leading cause of cancer deaths in the United States.”

Transgene's Cancer Vaccine Yields Positive Phase II Results
“Transgene has reported promising preliminary data from the randomized, open-label and controlled Phase IIb trial evaluating its therapeutic vaccine TG4010 as an adjunct to first line chemotherapy in patients with advanced non-small cell lung cancer.”

Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
“Pharmacyclics, Inc. announced that it has received a non-approvable letter from the U.S. Food and Drug Administration (FDA) for the company's new drug application (NDA) for Xcytrin(R) (motexafin gadolinium) Injection for the treatment of non-small cell lung cancer (NSCLC) patients with brain metastases.”

Global Pharma Seeks Cancer Drug Patents
“The objections by Indian pharma companies to Swiss drug maker Novartis seeking a product patent for its Glivec blood cancer medicine has not deterred other global drug firms from applying for patents in this drug category in India.”

Family to climb Kilimanjaro, fight cancer
Posted By Don Fraser
Posted 3 days ago
A St. Catharines family is hiking to the top of Africa to remember two grandparents, while giving a leg-up to a regional cancer-support centre.

On Feb. 18, the Gormans begin a six-day trek up and down the Tanzanian slopes of Mount Kilimanjaro — from a rainforest to its icy summit — to encourage donations to Wellspring Niagara.

“It’s appropriate we leave on Valentine’s Day and climb on Family Day,” said Mike Gorman, who is planning the expedition with wife Kristine and daughter Kelly, 12.

“This really is a family-generated idea and it’s about togetherness,” he said.


Week Ending January 06, 2008

Radon Second Only to Cigarette Smoking in Causing Lung Cancer - Home Testing for Radon is One Way to Fight It
“During January, National Radon Action Month, the U.S. Environmental Protection Agency and the U.S. Surgeon General urge Americans to test their homes for radon, a cancer-causing radioactive gas that claims tens of thousands of lives each year.”

Are CT Scans Causing Higher Cancer Rates?
“CT Scans could be putting Americans at a slightly higher risk of cancer, a recently-released study says. According to researchers at the Columbia University Center for Radiological Research, the 62 million CT Scans American’s receive every year could be increasing the cancer rate by as much as 2%. More disturbingly, the effects of CT scans on the cancer rates of children could be even more pronounced.”

Drug Safety, Tainted Food Among Year's Top Health Stories
MONDAY, Dec. 31 (HealthDay News) – “Widely used drugs with questionable side effects, and major recalls of foods consumed by Americans and their pets --both of those stories, plus a significant stem cell breakthrough, made the headlines in 2007.”

Delusion Lets Smokers Breathe Easy
“Most Australian smokers are in denial about their habit. Three in five smokers cling to 'self-exempting beliefs' that smoking-related diseases are caused by air pollution or genetics. A survey by the Cancer Council Victoria reveals that 60 per cent of smokers cling to "self-exempting beliefs" that smoking-related diseases such as heart and lung cancer are caused by air pollution or genetics.”

Lung Cancer Cells' Survival Gene Seen As Drug Target ScienceDaily (Dec. 29, 2007) — “One of the deadliest forms of cancer appears to carry a specific weakness.When a key gene called 14-3-3zeta is silenced, lung cancer cells can't survive on their own, researchers have found.”

Genetics Testing Pinpoints Cancer Risk
“Along with high-tech cancer fighting technology, a peaceful setting and specialty oncologists, Sletten Cancer Institute is the only cancer center in Montana that boasts a full-time genetic counselor.”

Toad Venom Studied in Cancer Treatment
“Toad venom extract, which has been used in China to treat cancer, had some benefit and no apparent side effects in a small Chinese study involving patients with hepatocellular carcinoma (a type of liver cancer), as well as lung and pancreatic cancer, researchers say.”

Diagnostic Imaging and Lung Cancer
“Lung cancer causes 30 percent of all cancer deaths per year making it the leading cause of cancer death in the United States on an annual basis.”

Infinity and MedImmune Initiate Phase 1b Trial of IPI-504 in Combination With Taxotere in Patients With Advanced Solid Tumor Cancers
“Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) and MedImmune announced that they have initiated a Phase 1b clinical trial of IPI-504 in combination with Taxotere(r) (docetaxel) in patients with advanced solid tumors.”

Treating Oft Ignored Non-cancer Health Issues After Cancer Diagnosis Prolongs Survival
ScienceDaily (Jan. 1, 2008) — “Receiving treatment for non-cancer health issues while being treated by specialists for cancer improves cancer survival rates according to a study published in the December 20 issue of the Journal of Clinical Oncology.”

Little Neck Cancer Survivor Co-Sponsors Relay for Life
“Little Neck resident Karen Buckner was diagnosed with lung cancer two years ago. She panicked, fretted and contemplated her mortality.”

Lung Cancer Researchers Honored With The "NEW" Hope Now Awards
“A new award, the "Hope Now Award for Lung Cancer Research," was announced to honor outstanding research efforts in lung cancer research. The award is established by Chawla Hope Initiatives, a philanthropic fund established by a Lung Cancer survivor and a retired CEO, Mr. Prem Chawla and is offered through Joan's Legacy.”

FDA Reviews New Amgen, J&J Data
“The Food and Drug Administration said it is reviewing additional information submitted by Amgen Inc. and Johnson & Johnson involving risks associated with the antianemia drugs Aranesp, Epogen and Procrit and "may take" additional regulatory action.”

No Change in Cancer Care 'Race Gap' Since 1990s
MONDAY, Jan. 7 (HealthDay News) – “Black cancer patients continue to be significantly less likely than white patients to receive treatment for lung, breast, colon and prostate cancers, new research finds.”

Cancer Patients Given A ‘Fighting Chance’
“As the first cancer counseling and resource center on the East End that offers completely free services, Fighting Chance - a non-profit, cancer patient advocacy group - gives patients and their families comprehensive support that covers all aspects of this life-altering diagnosis.”

Last Updated on Tuesday, 06 January 2009 05:51
Caring Ambassadors
Copyright • 2013
Caring Ambassadors
Site designed by Ferguson Lynch
Caring Ambassadors
P.O. Box 1748
Oregon City, OR 97045
503-632-9038 (Fax)